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During fertilization, the spermatozoon task is not limited to just deliver the male genome to 
the oocyte, it is beyond that. During the last stages of spermatogenesis, the spermatozoa 
develop to have a highly organized genome. The sperm DNA is compacted by nearly 85% 
of protamines and 15 % of histones carrying epigenetic signals, together with different kind 
of RNA molecules and proteins participate in post-fertilization events and mainly in 
embryo development.  
About 50% of infertility cases are referred to as idiopathic infertility, around 15% of it is 
due to genetic factors and 35% due to environmental factors. Tobacco smoke is one of the 
lifestyle factors that present a big threat for human health and it is believed to have an 
influence on male fertility and sperm quality by inducing epigenetic and/or genetic 
modulations on sperm genome. Thus, this study comes to fulfil a part in the remained gap 
in the comprehensive understanding of the expression and regulation of the genes in the 
human spermatozoa. 
The purposes of this study were first, to find out the effect of Tobacco smoke on sperm 
quality determined by standard parameters (WHO, 2010), sperm DNA maturity tested by 
Chromomycin A3 (CMA3) staining, sperm DNA fragmentation tested by TUNEL assay, 
and clinic outcomes after ICSI therapy. Second, to quantify the transcript levels of five 
nuclear proteins genes: H2BFWT, TNP1, TNP2, PRM1, and PRM2 by RT-PCR, correlate 
them with the previous parameters and determine the smoking effect on this gene 
expression and regulation. Finally, to determine the single nucleotides polymorphisms in 
three genes: H2BFWT, PRM1, and PRM2 by Sanger sequencing and their association to 
smoking and previous parameters. 
The study population (n=167) were male partners, randomly collected, of couples 
undergoing intracytoplasmic sperm injection (ICSI) therapy, in reproductive age (25-49 
years). The patients were divided into two groups: heavy-smokers group and non-smokers 
group. 
In heavy-smokers group a significant decrease (p<0.01) in standard semen parameters in 
comparison to non-smokers has been shown: sperm concentration (62.17 ± 51.68 mill/ml 
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vs. 88.09 ± 63.42 mill/ml), progressive motility (PR) (14.86 ± 10.95% vs. 27.31 ± 21.78%), 
and sperm normal morphology (4.01 ± 2.88% vs. 10.87 ± 12.11%).  
Besides, the mean percentage of protamine deficiency (CMA3 positivity) and sperm DNA 
fragmentation (sDF) were significantly higher (p<0.01) in heavy-smokers than in non-
smokers (33.30 ± 23.33% vs. 20.35 ± 13.43% and 26.86 ± 19.77% vs.14.23 ± 13.07% 
respectively). A significant positive correlation has been found between CMA3 positivity 
and sDF (r=0.484, p=0.0001) in the group of heavy-smokers, and no correlation (r=0.256, 
p=0.098) between these two parameters in the non-smokers group.  
In the present study, by comparing the ICSI results between the heavy-smokers and non-
smokers, the pregnancy rate was significantly higher in the group of non-smokers than the 
heavy-smokers group (0.60 ± 0.49% vs. 0.38 ± 0.48%, p=0.013), other parameters showed 
no significant differences. 
Furthermore, the transcript level of each studied gene mRNA (mean delta Ct) was 
differentially expressed between the heavy-smokers and non-smokers groups and this 
difference was highly significant (p<0.01). H2BFWT, TNP1, TNP2, PRM1 and PRM2 
genes were down-regulated in spermatozoa of heavy-smoker compared to non-smoker 
(Fold change<0.5) and were significantly correlated between each other (p<0.01). 
Moreover, the protamine mRNA ratio, in the current study, was significantly higher in the 
heavy-smokers group in comparison to the non-smokers group (0.60 ± 1.08 vs. 0.11 ± 0.84, 
p=0.001). 
In the non-smokers group, protamine ratio correlated positively with the expression levels 
of TNP2 (r=0.349, p=0.032) and PRM2 (r=0.488, p=0.001). However, in the heavy-
smokers group, it correlated positively to TNP2 transcript (r=0.307, p=0.004), PRM2 
transcript (r=0.445, p=0.0001), and H2BFWT transcript (r=0.342, p=0.001). Only in the 
group of heavy-smokers, the protamine ratio significantly correlates with CMA3 positivity 
(r=0.413, p=0.0001) and sDF (r=0.302, p=0.003). 
Moreover, the present study demonstrated the absence of a connection between genetic 
variations founded in H2BFWT gene (rs7885967, rs553509 and rs578953), protamines 
genes PRM1 (rs737008) and PRM2 (rs2070923 and rs1646022) and fertility alteration in 
heavy-smoker and non-smoker males. 
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In conclusion, the results of this study demonstrated that smoking has inverse effects on 
sperm quality, sperm DNA integrity, mRNA expression levels of H2BFWT, TNP1, TNP2, 
PRM1and PRM2 genes and protamine mRNA ratio, but has no effect on the nucleotides 
sequences of these genes. This suggests that the RNA of the studied genes and protamine 
mRNA ratio in the sperm of male partners of ICSI patients are good predictive factors to 


















Das Spermium hat während der Befruchtung mehrere Aufgaben. Zum einen muss das 
männliche Genom zur Eizelle. Des Weiteren entwickeln sich die Spermien in den letzten 
Stadien der Spermatogenese zu einem hoch organisierten Genom. Die Spermien-DNA wird 
aus Protaminen (ca. 85%) und Histonen (ca. 15%) gebildet, zusammen mit verschiedenen 
Arten von RNA-Molekülen und Proteinen. Diese sind vor allem an Prozessen nach der 
Fertilisation beteiligt und nehmen eine wichtige Rolle in der Embryonalentwicklung ein. 
Etwa 50% der Fälle von Unfruchtbarkeit werden als idiopathische Unfruchtbarkeit 
bezeichnet, davon sind 15% auf genetische Faktoren und 35% auf Umweltfaktoren 
zurückzuführen. Tabakrauch ist einer der Lebensstilfaktoren, die eine große Bedrohung für 
die menschliche Gesundheit darstellen. Es wird angenommen, dass Rauchen Einfluss auf 
die männliche Fruchtbarkeit und Spermienqualität hat, indem es epigenetische und/oder 
genetische Modulationen auf das Spermiengenom induziert.  
Ziel dieser Studie war es, zunächst die Wirkung von Tabakrauch auf die Spermienqualität 
zu ermitteln.Die Spermienqualität wurde bestimmt durch Standardparameter (WHO, 2010), 
die DNA-Integrität (gemessen mit Chromomycin A3 Färbung, CMA3) und die DNA-
Fragmentierung (gemessen durch den TUNEL-Test). Des Weiteren wurde das klinische 
Outcome nach ICSI Therapie dokumentiert. Transkriptionswerte von fünf atomaren 
Proteingenen wurden ebenfalls quantifiziert: H2BFWT, TNP1, TNP2, PRM1 und PRM2 
von RT-PCR.Es wurde untersucht, ob die Gene mit den bisherigen Parametern korrelieren 
und ob es einen Effekt des Rauchens auf die Genexpression, bzw. Genregulation gibt. Um 
die einzelne Nukleotid-Polymorphismen zu bestimmen, wurden 3 Gene (H2BFWT, PRM1 
und PRM2) durch Sanger-Sequenzierung untersucht.Ihre Assoziation mit dem Rauchen, 
sowie mit den anderen Spermienparametern wurde ebenfalls gemessen. 
Die Studienpopulation (n=167) waren männliche Probanden, die sich einer 
intrazytoplasmatischen Spermieninjektion (ICSI) unterzogen hatten. Das Alter betrug 25-49 
Jahre. Die Patienten wurden in zwei Gruppen eingeteilt: Die Gruppe der schweren Raucher 
und die Nichtraucher-Gruppe. 
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Bei der Gruppe der Raucher wurde eine signifikante Abnahme (p<0,01) bei den 
Standardparametern im Vergleich zu Nichtrauchern gezeigt: Spermienkonzentration (62,17 
± 51,68 mill/ml vs. 88,09 ± 63,42 mill/ml), progressive Beweglichkeit (PR) (14,86 ± 
10,95% vs. 27,31 ± 21,78%) und Spermienmit normaler Morphologie (4,01 ± 2,88% vs. 
10,87 ± 12,11%) waren bei Rauchern im Vergleich zu den Nichtrauchern reduziert. 
Außerdem war der Mittelanteil von Protamin-Mangel (CMA3-Positivität) und der DNA-
Fragmentierung von Spermien (sDF)  bei Rauchern signifikant höher (p<0,01) als bei 
Nichtrauchern (33,30 ± 23,33% vs. 20,35 ± 13,43% und 26,86 ± 19,77% vs. 14,23 ± 
13,07%). Es wurde eine signifikante, positive Korrelation zwischen die CMA3-Positivität 
und sDF (r=0,484; p=0,0001) in der Gruppe der Raucher festgestellt. Dagegen gab es keine 
Korrelation (r=0,256; p=0,098) zwischen diesen beiden Parametern in der Nichtraucher-
Gruppe. 
In der vorliegenden Studie war die Schwangerschaftsrate nach ICSI in der Gruppe der 
Nichtraucher deutlich höher als die der Raucher-Gruppe (0,60 ± 0,49% vs 0,38 ± 0,48%; 
p=0,013).  
Darüber hinaus wurde die Transkriptionsstufe jedes untersuchten Gens mRNA (mean delta 
ct) zwischen den Rauchern und Nichtrauchern differenziert ausgedrückt.Dieser Unterschied 
war signifikant (p<0,01). Die Gene H2BFWT, TNP1, TNP2, PRM1 und PRM2 wurden in 
Spermien der Raucher im Vergleich zum Nichtraucher (Foldchange<0,5) herunterreguliert 
und signifikant miteinander korreliert (p<0,01). Zudem lag das Protamin-MRNA-
Verhältnis in der Raucher-Gruppe deutlich höher (0,11 ± 0,84 vs. 0,60 ± 1,08, p=0,001). 
In der Gruppe der Nichtraucher korrelierte das Protaminsverhältnis positiv mit den 
Ausdruckstufen TNP2 (r=0,349; p=0,032) und PRM2 (r=0,488; p=0,001). In der Gruppe 
der Raucher korrelierte es jedoch positiv mit TNP2-Transkript (r=0,307; p=0,004), PRM2-
Transkript (r=0,445; p=0,0001) und H2BFWT-Transkript (r=0,342; p=0,001). Nur in der 
Gruppe der Raucher korreliert das Protaminsverhältnis signifikant mit CMA3-Positivität 
(r=0,413; p=0,0001) und sDF (r=0,302; p=0,003). 
Darüber hinaus hat die vorliegende Studie gezeigt, dass es keinen Zusammenhang zwischen 
genetischen Variationen gibt, die im H2BFWT-Gen (rs7885967, rs553509 und rs578953), 
Protaminen-Gen PRM1 (rs737008) und PRM2 (rs2070923 und rs1646022) vorkommen. 
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Zusammenfassend haben die Ergebnisse dieser Studie gezeigt, dass Rauchen einen 
negativen Einfluss auf die Spermienqualität hat.Die Spermienqualität, die mRNA-
Expressionsstufen der H2BFWT, TNP1, TNP2, PRM1-und PRM2-Gene und das Protamin- 
mRNA-Verhältnis waren bei Nichtrauchern reduziert, hatten aber keine Auswirkungen auf 
die Nukleotid-Sequenzen dieser Gene. Dies deutet darauf hin, dass die RNA der 
untersuchten Gene, sowie das Protamin-mRNA-Verhältnis in den Spermien männlicher 
Partner von ICSI-Patienten gute Vorhersage-Faktoren sind, um die Spermienqualität und 
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Infertility is a big problem that many couples worldwide have to face. In fact, it is affecting 
nearly 15% of the couples who, according to the World Health Organization (WHO, 2010), 
fail to geta clinical pregnancy after 12 months or more of regular unprotected sexual 
intercourse (WHO, 2010). 
A population based-study carried out by Agarwal et al. (2015) to estimate male infertility 
distribution around the world, has shown that the male factor distribution in the infertility 
was between 20% and 70% and the proportion of infertile men was on the 2.5% - 12% 
range.  
Infertility or subfertility is related to health problems that can be the consequence of many 
factors. 50% of cases are referred to as idiopathic infertility and around 15% of these cases 
are due to genetic factors that include chromosomal aneuploidy, chromosome 
microdeletions, structural and numerical Karyotype anomalies (Harton & Tempest, 2012), 
chromosome-linked copy number variations (CNVs), variable number tandem repeats 
(VNTRs) and single nucleotide polymorphisms (SNPs) associated with  genes with an 
endocrine function (ESR1, ESR2, AR, etc.), specific function in spermatogenesis (PRM1, 
PRM2, H2BFWT, etc.) or ordinary cell function (CYP1A1, MTHFR, NOS3, etc.) (Krausz 
et al., 2015). 
In other idiopathic male infertility cases, environmental and lifestyle factors, such as 
nutrition, drinking alcohol, physical activity and tobacco smoke, play an important role in 
the aggravation of infertility problems. 
In fact, external exposure to toxicants leads to different alterations during the various 
phases of spermatogenesis (mitotic, meiotic and post-meiotic) (Beal et al., 2017). As a 
matter of fact, it has been confirmed that male fertility impairment is growing and that this 
might be associated with environmental factors and lifestyles. In this study, we have 
focused on tobacco smoke and its effect on the spermatozoa structure, the function nuclear 
protein gene polymorphism and the sperm potential to fertilize the oocyte by analysing 
semen samples of heavy-smoker and non-smoker patients undergoing intracytoplasmic 
sperm injection (ICSI) therapy.  
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1.1. Sperm chromatin organization 
It took 50 years to discover the two major components of the sperm chromatin: DNA and 
protamine. The beginning of this research was in 1865 when Gregor Mendel established the 
laws of heredity (Mendel, 1865). 
Four years later, Friedrich Miescher began his research about the cells and their chemical 
composition by isolating the proteins and discovered an acid-insoluble structure that he 
called the Nuclei (Miescher, 1869). Later on, the nucleus accumulated from the human cells 
was not enough for his study, so he decided to use salmon sperm cells instead. At this time, 
he isolated a highly basic protein, which he called protamine. Then, he reported that the 
major structure of the spermatozoa head was DNA and protamine and that they were 
attached in a salt-like state (Miescher, 1874).The most research on the protamine molecule 
was carried out by Kossel and his team for almost 3 decades (Kossel, 1898; Kossel & 
Dakin, 1904; Kossel & Dakin, 1905; Kossel & Edlbacher, 1913). 
1.2. The spermatogenesis 
Sexual reproduction is a type of reproduction where two haploid cells called spermatozoon 
and oocyte fuse together. These cells are obtained through a series of cell phases and 
divisions including nuclei and chromatin packaging and function changes in a 
differentiation process called spermatogenesis starting from diploid somatic cells called 
spermatogonium. This process is the main key to have successful fertilization. It includes 
several series of cellular, chromatin structural and functional modifications (Figure 1).  
Spermatogenesis begins with differentiation via the mitosis of spermatogonial cells into 
primary spermatocytes. Then, the diploid spermatocytes (44 chromosomes, XX or XY) 
undergo a meiotic phase (meiosis I and meiosis II) to produce haploid spermatids 
containing only one copy of each chromosome (22, X or Y). Later, the spermatid undergoes 
a series of morphological changes (Head, midpiece and tail) and their chromatin structure 
and function change (Balhorn, 2018).  
In fact, there are imprinted genes in the male genome, epigenetic changes in the DNA and 
nucleoproteins that edit the chromatin to make it ready to control the embryonic growth and 
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development (Canovas & Ross, 2016) and step-by-step the chromatin will be genetically 
silenced in the spermatozoa (Ren et al., 2017). 
 
Figure 1: Themajor events in the life of sperm during spermatogenesis and fertilization; Cellular 
changes (left) and chromatin changes (right). [Adapted from Barrachina et al., 2018] 
 
Spermatogenesis is controlled through several hormones. The first control is through a 
neurological pathway; the gonadotrophin-releasing hormone (GnRH) secreted by the 
hypothalamus provokes the adenohypophysis to excrete the follicle-stimulating hormone 
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(FSH) and luteinizing hormone (LH). The LH provokes the Leydig cells to produce the 
Testosterone, and the FSH assists the Sertoli cells to support the spermatozoa during the 
different phases of spermatogenesis. Beside FSH and LH there are other hormones, such as 
prolactin and the growth hormone, which play crucial roles during spermatogenesis 
(Sharma & Agarwal, 2011). 
 
 







1.3. The chromatin remodelling during spermiogenesis 
In order to obtain a hydrodynamic sperm head and to protect the paternal genome from any 
modifications in the male orfemale reproductive tracts, the human sperm DNA, in early 
spermiogenic phases, undergoes major cellular and nuclear changes (Ward & Coffey, 
1991).  
First, the spermatid undergoes the Golgi phase, which is marked by the formation of 
polarity. The Golgi apparatus, which evolves later on the acrosome and synthesized 
proteolytic enzyme, appears in the head. Mitochondria accumulate in the midpiece and the 
axoneme starts to form the distal centriole. Next, one of the centriole pair elongates to form 
the tail or flagellum (Russell et al., 1993).   
Besides, the chromatin in the elongated nucleus becomes ten times more compact than the 
chromatin in the nucleus of a somatic cell through progressive modifications (Braun, 2001) 
(Figure 3). 
So, in early spermiogenic phases, major chromatin packaging takes place. The nucleosome-
bound DNA configuration will first be destabilized by hyperacetylation of the canonical 
histones, which will neutralize the positive charge of lysine,  reducing their affinity for 
DNA and by the DNA topoisomerase II (topo II), which will cause double and single DNA 











Figure 3: A representation of the difference in the chromatin packaging between a somatic cell (left) 
and a sperm (right). The chromatin is converted from a nucleo-histone structure (solenoid loop) into a 
nucleo-protamine structure (Toroid: doughnut loop). Post-translational modifications of the proteins 
facilitated the transition histone-protamine: acetylation, ubiquitination and phosphorylation of histone 
H4, phosphorylation and dephosphorylation of the transition proteins. [Adapted from Braun, 2001]. 
 
The "canonical histones" are composed of the core histones (H2B, H2A, H3, and H4) and 
the linker histone (H1), will be replaced by their testis-specific histone counterparts. These 
histones are called "histones variants" and start to appear during different stages of 
spermatozoon formation and they are found in lower quantities during the cell cycle 
(Cheema & Ausió, 2015) (Figure 4). Among these histones, there are H2A variants which 
are major players like H2A.Bbd (González-Romero et al., 2008), H2B variants like 
H2BFWT (Churikov et al., 2004a), H3 variants like H3.T (Witt et al., 1996), and H1 
variants like H1.T and H1.T2 (Tanaka et al., 2005). Some of these histone variants are 
present only in masculine germ cells (Talbert & Hanikoff, 2010).  
Churikov et al. (2004b) demonstrated that the TH3 histone variant is shown in 
spermatogonia, TH2A and TH2B, prior to meiosis, combined with the chromatin of 
spermatocytes. However, TH1 or H1.t is found at the end of the meiotic prophase. 
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Moreover, there are posttranslational modifications (PTM) of histones that are also 
important for the good progress of the spermiogenesis (Carrell, 2012; Godmann et al., 
2007). During the elongated spermatids phase, the H3 and H4 are acetylated and 
consequently, the interactions between these histones and the sperm DNA are relaxed, 
especially in the regulatory regions of genes which contribute to embryonic development 
(Nair et al., 2008; Sonnack et al., 2002). The H4 methylation increases during the 
differentiation of the spermatogonia to spermatid (Luense et al., 2016), but decreases in the 
elongated spermatids (Sonnack et al., 2002). H3 histone is methylated in the round 
spermatids and this methylation has been demonstrated to mark the regulatory sites on 
evolutionary repressed genes, which are important for both gamete differentiation and 
embryo development (Godmann et al., 2007; Hammoud et al., 2009; Khalil et al., 2004). 
It has been demonstrated that 10-15% of canonical histones and their variants remains 
bound to DNA in the mature human spermatozoa (Bench et al., 1996; Gatewood et al., 
1990; Wykes & Krawetz, 2004). It concerns mainly the transcription sites of genes in 
sperms that are important for the preservation of the paternal genome epigenetics for their 
later expression during early embryonic development (Carrell & Hammoud, 2009; Ihara et 
al., 2014). The regulatory sequences (Brykczynska et al., 2010; Castillo et al., 2014), 
microRNA clusters, transcription factors, paternally imprinted genes (Hammoud et al., 
2009), the centromeric and telomeric DNA (Zalenskaya & Zalensky, 2004), retroposons 
(Pittoggi et al., 1999), matrix associated regions (Ward, 2009), and genes that produce 
rRNA are transcribed at the final stages of spermatogenesis (Sillaste et al., 2017). 
After spermatocytogenesis, the chromatin structural changes will be more obvious when 
two smaller more basic proteins (10-20% lysine and arginine) named "Transition proteins" 
TP1 and TP2 are synthesized and deposed at the mid-stage of spermatid formation (Figure 
4). 
TP2 (13kDa) appears in step 1 and TP1 (6.2kDa) appears in step3 (Steger et al., 1998). At 
this time the majority of the core histones are eliminated and the chromatin structure 
becomes more condensed. 
Pradeepa & Rao (2007) have reported that TP1 plays the main role in the destabilization of 
the nucleosome structure and the initiation of gene transcription termination when TP2 is 
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attached to CG rich sequence by zinc fingers. Also, it is important for the chromatin 
condensation progress (Zhao et al., 2001). It has also been shown that TP1 facilitates the 
repair mechanism of the DNA strand alterations (Caron et al., 2001).   
As their name indicates, these proteins stay only for a short period of time attached to the 
DNA. Therefore, they are modified in arginine and lysine residues by methylation, 
acetylation, and phosphorylation to lose their ability of attachment to the sperm DNA 
(Nikhil et al., 2015).  Moreover, the transition proteins have been shown to be important 
not only for the chromatin condensation procedure but also for the DNA damage repair 
caused during the histones replacement (Boissonneault, 2002). The TPs are then replaced 
by a set of small (5-8 kDa) highly basic proteins called "protamines" in the late spermatid 
stage (Figure 4). The sperm protamines 1 and 2 are encoded each by a single gene (PRM1 
for P1 and PRM2 for P2) located in a cluster of genes beside the TNP2 gene.  
They are located on chromosome 16 (16p13.13) (Oliva, 2006; Martins & Krawetz, 2007). 
The mRNA of these proteins is silenced and translated after gradual modulation of sperm 
nuclear proteins, histones to transition proteins. This step is important to ensure a good 
process of chromatin repackaging (Chromatin decondensation) after the intrusion or 
injection of a spermatozoon into the cytoplasm of the oocyte (Hecht, 1989; Kleene & 
Flynn, 1987; Lee et al., 1995). 
The sperm protamine 1 (P1) (51 AA) is the first to be synthesized as a mature protein 
(Green et al., 1994; Queralt et al., 1995). The protamine 2  is created as a precursor which 
is twice the size of P1 (101 residues) and undergoes cleavage by proteolysis after its 
deposition onto sperm DNA in order to eliminate short fragments of the peptide (Martinage 
et al., 1990; Green et al., 1994). These proteins are reported to be expressed in equal 
quantities (P1/P2 ratio ≈ 1) (Corzett et al., 2002; Aoki et al., 2005). Nanassy et al. (2011) 
suggested a clinical value of the protamine ratio of between 0.54 and 1.43 for a fertile, 




Figure 4: Major chromatin structure remodelling events during spermiogenesis. [Adapted from 
Teperek & Miyamoto, 2013] 
These proteins have a characteristic constitution, mainly composed of arginine (48%) and 
cysteine residues (Figure 5) (Balhorn, 1989; Balhorn, 2007; Oliva & Castillo, 2011). The 
arginines are highly positive charged residues which form a highly ordered nucleo-
protamine complex (Toroid) with the negatively charged sperm DNA (Figure 6) (Ward, 
2009; Oliva & Castillo, 2011).  
The cysteine residues are responsible for the formation of inter- and intra-protamine 
disulfide bridges (S-S), which stabilizes the nucleo-protamine complex (Lewis et al., 2003; 
Vilfan et al., 2004; Balhorn, 2018). It is known that zinc is abundant in human sperm nuclei 
(Morisawa & Mohri, 1972) and that it is likely to get trapped by the S-S (Bedford et al., 
1973). The Cys2/His2 motif of P2 is a zinc finger domain, which leads to the appearance of 
zinc bridges responsible for the high stabilization of the chromatin in the mature 
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spermatozoa and in the cessation of transcription until the fertilization (Bianchi et al., 1992; 
Björndahl & Kvist, 2009). 
 
Figure 5: The human sperm protamine sequences. The arginine residues are distributed in clusters 
(red). The cysteine residues (asterisk) are responsible for the formation of the disulfide bonds (inter-or 
intramolecular) with molecules that are adjacent to protamine. [Adapted from Oliva & Castillo, 2011] 
 
Figure 6:The sperm chromatin remodelling during spermiogenesis: from a histone solenoid structure to 




1.4. Sperm DNA alterations and their consequences on male fertility and ART 
outcomes 
Any defect occurring in one of the chromatin remodelling steps may lead to damage of the 
DNA integrity and may influence the sperm motility and morphology resulting in 
asthenozoospermia, teratozoospermia and male infertility.  
As a result, the sperm will be incapable of penetrating the oocyte and in cases where the 
sperm is intruded or injected into the oocyte, the fertilization process will fail (Spano et al., 
2005). Recently, as shown in a large number of cases, such failure can be overcome 
through different technologies like intrauterine insemination (IUI), in vitro fertilization 
(IVF), and intracytoplasmic sperm injection (ICSI) known as assisted reproductive 
technologies (ARTs), but the probability of implantation failure and problems during the 
embryonic development could still be high (Bungum & Oleszczuk, 2018). 
The traditional way of diagnosing male infertility is by determining the classical semen 
parameters, as described in the World Health Organization laboratory (WHO, 2010). 
It is obvious that these parameters were not good prognostic factors of a man’s fertility and 
of ART success. This has led to more focus on the genomic side of the sperm. In fact, many 
studies have revealed that the DNA injuries in sperm may affect the pregnancy results in 
IUI (Muriel et al., 2006; Bungum et al., 2007; Bungum & Oleszczuk, 2018). In the last 
decade, it has also been shown that DNA impairment can affect the fertilization rate, pre-
embryo development and thus the pregnancy or miscarriage (Hammadeh et al., 2006; 
Bakos et al., 2008; Frydman et al., 2008; Tarozzi et al., 2009). Moreover, others have 
demonstrated that no significant correlation was observed between the sperm chromatin 
impairments, the fertilization rate (Henkel et al., 2003), the embryo quality (Benchaib et 
al., 2003) and the   IVF/ICSI outcomes (Chohan et al., 2004). Despite that, many studies 
used different techniques for sperm DNA structure or DNA fragmentation index (DFI) 
measurement; it is still not used as a standard parameter to test male infertility or as a 
predictor of ART success. 
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1.5. Sperm chromatin maturity assessment (Tests) 
Several function tests have been proposed to explore sperm fertilizing ability and to predict 
the rate of ART outcome. However, in the literature there is still controversy about the 
benefits of using these tests. After semen analysis, normal semen parameters provide no 
firm conclusion to the clinicians either about the fertility status of the patient or the 
outcomes of infertility treatment. Various studies demonstrated that abnormalities during 
the sperm chromatin organization may lead to male infertility (Sakkas & Tomlinson, 2000; 
Spanò et al., 2000; Saleh et al., 2002) and may subsequently influence the fertilization and 
the embryo quality and development (Gannon et al., 2014; Simon et al., 2014). This means 
that sperm DNA analysis with the standard semen analysis may help to reveal hidden sperm 
DNA abnormality in men with idiopathic infertility. Because of the increasing evidence for 
DNA integrity and its importance for the ART outcome, many methods have been 
developed in the last decade to reveal any changes in the sperm chromatin status and 
maturities, such as fragmentation and protamination. But the use of these techniques as 
complementary biomarkers besides semen analysis is still controversial. 
Many assays are used to evaluate the sperm chromatin status, each one concentrating on a 













Table 1: Sperm chromatin abnormalities assessment assays (according to Agarwal et al., 
2017) 
Assessment Test Variable Method 
Acidic aniline blue (Hammadeh 
et al., 1996) 
Nuclear maturity  Optical microscopy 
Toluidine blue stain (Erenpreisa 
et al., 2003) 
DNA fragmentation Optical microscopy 
Chromomycin A3  
(Manicardi et al., 1995) 
Nuclear maturity (DNA protein 
composition) 
Fluorescent microscopy 
Sperm chromatin dispersion 
(Fernandez et al., 2003) 
DNA fragmentation Fluorescent microscopy 
DNA breaking detection-
fluorescent 
in situ hybridization (Fernandez 
et al., 2000) 
In situ nick translation 
(Gorczyza et al., 1993) 





Acridine orange (Hammadeh et 
al., 2001) 
DNA denaturation (acid) Fluorescent microscopy 
Flow cytometry 
TUNEL (Barroso et al., 2000)  DNA fragmentation Optical microscopy 
Fluorescent microscopy 
Flow cytometry 
Comet (neutral) (Singh et al., 
1988) 
(alkaline) (Singh et al., 1989) 




Sperm chromatin structure 
(Evenson et al., 1991) 
DNA denaturation (acid/heat) Flow cytometry 
8-OHdG measurement 
(Shen & Ong, 2000) 
8-OHdG High-performance liquid 
chromatography 
 
8-OHdG, 8-hydroxy-2-deoxyguanosine; dsDNA, double-stranded DNA; ssDNA, single-stranded DNA 
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1.6. Gene expression in human spermatozoa 
The spermatozoon is a unique differentiated cell that resulted from extremely ordered 
processes.  Transcription is a remarkable process preserved during the first steps of 
spermiogenesis until the evolution of the round spermatids. At this step, the mRNAs are 
synthesized intensively under the control of a set of specific transcription factors (Grégoire 
& Boissonneault, 2011).  
Then, the transcripts which are needed to complete in the assistance of the mature 
spermatozoa evolution are kept as ribonucleoproteins (RNPs). At the same time, the 
majority of cytoplasm with its constituents, including RNA, will be eliminated (Cooper, 
2005), and the histones are replaced by protamines, as previously described, which leads to 
a highly compacted DNA. This event leaves the sperm cell transcriptionally inert and 
lacking a translation process due to ribosomal RNA (rRNA) cleavage (Johnson et al., 
2011). 
The remaining transcripts, shown by RNA sequencing (RNA-Seq), are coding and non-
coding RNAs which contain both fragmented and submissively non-degenerated mRNAs, 
mi (micro), si (small interfering), lnc (long non-coding), and pi (Piwi-interacting)-RNAs 
(Figure 7) (Jodar et al., 2013; Sendler et al., 2013). 
 
Figure 7: Spermatozoal RNAs population in normal sperm samples. The rRNA class was the most 
abundant followed by the mitochondrial RNA (mitoRNA), small non-coding RNAs (snc-RNAs) and 
others. [Adapted from Jodaret al., 2013] 
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The composition of a mammal’s spermatozoal RNA, like in humans, is the most 
distinguishable structure. The majority of germ cell transcriptome studies that provided a 
general view of the spermatozoal RNA population were performed on the microarray 
(cDNA/ Oligonucleotide). Ostermeier et al. (2002) found that almost 3000-7000 different 
coding RNAs existed in human mature spermatozoa. In another study, they demonstrated 
that sperm transcripts originating from the earlier phases of spermatogenesis reflect 
testicular events that had happened previously (Ostermeier et al., 2005).  
Recently, as a result of various studies on the RNA content in mature sperm, an alternative 
way has evolved of diagnosing male fertility problems. A number of infertility phenotypes 
have been associated with altered transcripts; Oligozoospermia (Ferlin et al., 2010; 
Montjean et al., 2012), Asthenozoospermia (Jedrzejczak et al., 2007; Kempisty et al., 2007; 
Chen et al., 2012; Jodar et al., 2012; Abu-Halima et al., 2013; Yatsenko et al., 2013; 
Bansal et al., 2015), oligoasthenozoospermia (Li et al., 2011; Zheng et al., 2011; Abu-
Halima et al., 2013; Shen et al., 2015).  
Thus, it is obvious that sperm RNA profile depends on the testicular microenvironment and 
consequently provides an idea of how environmental and pathological agents can affect this 
microenvironment.  
Others have tried to find a correlation between the presence of the remaining RNA in 
spermatozoa with regulative functions and fertilization, early embryo development (Jodar 
et al., 2013; Sendler et al., 2013), and progeny phenotype (Ostermeier et al., 2004, Jodar et 
al., 2013).  
Furthermore, Garrido et al. (2009) and García-Herrero et al. (2011) pointed out the 
possibility of using a group of molecular biomarkers from the spermatozoal RNA profile as 
a predictor of ART’s outcomes. 
Jodar et al. (2015) identified 648 Sperm RNA elements (SREs), derived from 285 genes, 
that can be used to make a prediction about the fertility treatment for idiopathic sub-fertile 
couples and its success rate, as demonstrated, for example, in the live birth rate.  
A similar study conducted by Burl et al. (2018) on the same SREs concluded that RNAs 
predict not only live birth success but also could even indicate the human health situation. 
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1.7. Tobacco smoke as a lifestyle factor influence on male infer tility 
Tobacco consumption represents one of the biggest worldwide threats to human health. 
Despite efforts worldwide to make people aware of its consequences on health, there are 
still 1.1 billion smokers worldwide (WHO, 2018).  
Because of its deadly toxic chemical combinations of at least 7000 chemicals, tobacco 
smoke causes the deaths of over 6 million people per year (Drope et al., 2018). More than 
70 of these chemicals are carcinogens, 40 are malignant and more than 400 chemicals, such 
as cadmium, nicotine, cotinine, lead, and carbon monoxide, are toxic (Kumar et al., 2011; 
Drope et al., 2018). 
This could cause damage in almost all the human organs, for example, in the lungs, heart, 
circulatory system, immune system, and male and female reproductive systems (Drope et 
al., 2018). 
1.7.1. The relationship between tobacco smoke and male fertility alterations 
Various studies have been conducted to evaluate the effects of tobacco smoke on human 
sperm parameters: approximately 113 studies on sperm count and concentration, 94 studies 
on sperm morphology and 25 studies on sperm vitality (Beal et al., 2017). But none of them 
have definitely confirmed the influence of smoking on male fertility.  
Contradictory findings have in fact been reported concerning the influence of tobacco 
smoke on standard semen parameters. Some studies have found that smoking is correlated 
with a decline in semen volume, count, motility and morphology (Hammadeh et al., 2010; 
Zhang et al., 2013; Hamad et al., 2014; Al-Turki, 2015) but others have not found this 
association (Davar et al., 2012; Kumar et al., 2014; Moretti et al., 2014).  
In addition, it has been reported a dose-response relationship between cigarette smoking 
and the quantity and morphology of spermatozoa (Zhanget al., 2013), and semen volume 
(Anifandiset al., 2014). 
Other researchers compared the hormone levels between smokers and non-smokers and 
found that smokers have a higher concentration of FSH and LH and a nadirlevel of 
testosterone, compared to non-smokers (Mitra et al., 2012; Jeng et al., 2014).  
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Al-Matubsi et al. (2011) demonstrated that the concentrations of testosterone and LH were 
higher in smokers but the FSH level was not different between non-smokers and smokers. 
These studies showed that tobacco could affect both the Leydig and Sertoli cells, which 
influence the spermatogenesis process.  
Moreover, smoking can also cause hypoxia (lack of oxygen) (Jensen et al., 1991), which 
affects the important metabolic pathways and consequently the different stages of 
spermatogenesis, causing impairments in testis function (Harlev et al., 2015). 
1.7.2. The relationship between tobacco smoke and damage to the DNA of sperm 
Temporary sperm DNA single-strand breaks (SSBs) and double-strand breaks (DSBs) are 
genetically programmed and are needed to facilitate both the initiation of the chromosomal 
recombination (crossing-over) throughout the meiotic prophase I (Bannister &Schimenti, 
2004) and the sperm chromatin repackaging. These breaks are observed in the round and 
elongating spermatids and are important for the alleviation of torsion stress in the DNA 
strand, which will facilitate the histone-protamine transition (Bench et al., 1998; Carrell & 
Liu, 2001).  
These breaks are created and ligated by an enzyme, named type II DNA topoisomerase 
(Topo II) (De Yebra et al., 1993; Kierszenbaum, 2001). Bakshi et al. (2001) have studied 
the hormonal regulation of Topo II and have concluded that its activity is androgen-
dependent. 
Moreover, Tweed et al. (2012) demonstrated that nicotine is an endocrine disruptor because 
it affects the hypothalamic-pituitary-end organ axes. These endocrine disruptors may alter 
the activity of Topo II, which may have a consequence on DNA integrity. 
A second process leading to sperm DNA damage is the formation of the DNA adduct that 
are constituted after the DNA has bound to a chemical, such as acetaldehyde and 
benzo[a]pyrene in cigarette smoke, that causes cancer (Zenzes et al., 1999 (a & b); 
Bengum, 2012; Phillips & Venitt, 2012). A number of studies have shown that there is a 
correlation between altered sperm hormones and high DNA adduct levels (Horak et al., 
2003; Gaspari et al., 2003). 
18  
 
It has also been demonstrated that this adduct might not be repaired by the oocyte and may 
be transferred to the zygote (Perrin et al., 2011).  
Another reason for sperm DNA damage is oxidative stress (Figure 8). The cigarette smoke 
contains an elevated number of reactive oxygen species (ROS), such as free radicals, 
hydroxyl (OH), superoxide (O2-), and hydroperoxyl (HO2) radicals, and non-radical 
species, such as hydrogen peroxide (H2O2) (Thomas et al., 2008). On the other hand, 
spermatozoa are vulnerable and can be damaged because of their plasma membrane being 
rich in polyunsaturated fatty acid that constitutes a substrate for ROS production and 
reduces the amount of scavengers in the cytoplasm, such as the ROS-metabolizing 
enzymes, ascorbate and uric acid (Alvarez & Storey, 1995; De Lamirande & Gagnon, 
1995).  
Moreover, the exchange between histone-protamine during spermiogenesis is also 
important because an incomplete protamination will expose the sperm DNA to an elevated 
risk of oxidative attack, which will damage it (Giwercman & Spanó, 2018). A correlation 
has been shown between tobacco smoke, altered spermatogenesis and variations in protein 
levels, such as protamine (protamine ratio) (Hammadeh et al., 2010; Hamad et al., 2017) 




Figure 8: Diagram presenting the main causes of oxidative stress. (G6PD: glucose-6-phosphate 
dehydrogenase; NADPH: nicotinamide adenine dinucleotide phosphate). [Adapted from Pereire et al., 
2017] 
1.7.3.The relationship between tobacco smoke and molecular alterations (aneuploidy, 
genetic and epigenetic) in correlation to male infertility 
The Sertoli cell barrier (SCB) known as the blood-testis is thought to be a protective barrier 
for the germ cells from the majority of toxicants (Smith & Braun, 2012). However, a 
contradictory finding has been reported (Yauk et al., 2015). The genotoxic agents included 
in cigarette smoke pass through the testis-barrier (Pacifici et al., 1993; Vine et al., 1993; 
Pacifici et al., 1995; Zenzes et al., 1999 (a)) and reach the spermatozoa genome in different 




Figure 9: Divergent mutations that can occur during spermatogenesis after exposure to an external 
disturbance. [Adapted from Beal et al., 2017].(A) because of her position (open side of the blood-testis 
Barrier), the spermatogonia are more vulnerable to external exposure like toxicant which is leading to 
an increase in the insertions/deletions (indels) and single nucleotides polymorphisms (SNPs).(B) When 
she passes the testis barrier, the spermatogonia divide into two spermatocytes type I (spcI) which go 
throughout two meiotic divisions. At this stage, chromosomal recombination may lead to chromosomal 
perturbations and aneuploidies. (C) During his differentiation of formed spermatids to spermatozoon, 
the sperm DNA became more compacted which lead to a deficiency in DNA may repair which leads to 
DNA strand breaks and chromosomal rearrangement (post-fertilization). 
Furthermore, many designed studies have examined the association between tobacco smoke 
and the frequency of the mutations in spermatogonia. Most of the studies were carried out 
on rodents and showed that both mainstream and sidestream cigarette smoke increased the 
mutation frequency in the spermatogonial stem cell (Stoichev et al., 1993; Yauk et al., 
2007; Marchetti et al., 2011).  
In a human study, Linschooten and his colleagues demonstrated that the risk of the 
transmission of mutations, type tandem repeat minisatellite, to offspring are four-times 
higher in smokers than in non-smokers (Linschooten et al., 2013). 
Furthermore, the meiosis process during spermatogenesis is important and any alteration 
could lead to numerical and/or structural chromosomal changes. It has been reported that 







number of chromosomes 22, 21, 20, 15, and 8 (Demirhan et al., 2011). Another study 
showed that the spermatozoa of male smokers contain a high frequency of disomy in 
chromosomes 3 and XY (Pereira et al., 2014). 
Chromatin remodelling during spermiogenesis is also an epigenetic mechanism, 
characteristic of spermatozoa. Male smoking has been associated with histone-to-protamine 
transition deficiency in sperm, alteration in protamine (P1 to P2) ratio (Hammadeh et al., 
2010; Yu et al., 2014; Hamad et al., 2017), and alterations in the histone (H2B)-to-
protamine ratio (Hamad et al., 2014).  
A correlation was demonstrated between the variations in the xenobiotic metabolism genes, 
such as glutathione S-transferases (GSTs), N-acetyltransferase (NAT2) (Yarosh et al., 
2015), the enzyme Cytochrome P450 (CYP1A1) (Yarosh et al., 2013) and idiopathic 
infertility in smokers.  
What is more, tobacco smoke is one of the main environmental factors that modify DNA 
methylation (Joubert et al., 2012; Philibert et al., 2012; Shenker et al., 2013). In our own 
laboratory in fact, a correlation between methylation and infertility in male smokers has 




1.8. The purpose of the study 
The histone-protamine transition in sperm chromatin is very important for sperm maturity. 
Thus, in this particular study, we had the following aims: 
1. to investigate the effects of tobacco smoke on standard sperm parameters, sperm 
maturity and sperm DNA integrity; 
2. to determine the gene expression of some primordial nucleoproteins in sperm 
chromatin condensation: H2B histone family, H2BFWT testis-specific encoded by 
H2BFWT gene, spermatid nuclear transition protein 1 encoded by TNP1 gene, 
spermatid nuclear transition protein 2 encoded by TNP2 gene, protamine 1 encoded 
by PRM1, protamine 2 encoded by PRM2, in semen samples of  heavy-smoker and 
non-smoker patients undergoing intracytoplasmic sperm injection (ICSI) therapy; 
3. to find out the influence of tobacco smoke on the paternal genome by studying the 
variation in the DNA sequence of three of these investigated protein genes, namely, 

















2. MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Study population 
Semen samples (n= 167) were collected randomly from male partners of couples 
undergoing ICSI treatment. Each patient had a physical examination and was interviewed 
following an organized questionnaire (Medical history, Job, Lifestyle and tobacco smoke). 
The participant who smokes more than one pack/day for 10 years or 2 pack/ day for 5 years 
was considered as heavy-smoker, and the participant who did not smoke was considered as 
a non-smoker. The individuals were in reproductive age (25-49 years). 
The inclusion criteria of patients were males who did not have cryptorchidism, present or 
past cancer treatment, genetic abnormalities (Klinefelter's syndrome or Y-chromosome 
microdeletion), hypogonadotropic hypogonadism (hormonal disorder), drug abuse, 
varicocele,   and/or recent fever episode, and female partners without any history of female-
related cause of subfertility (endometriosis, tubal occlusion, or ovulatory disturbance) and 
no surgical or medical infertility treatment in the last three months before undergoing ICSI. 
2.1.2. Reproduction and Andrology laboratory materials 
Reagent or chemical Company 
Combur 2 Test LN Roche, Switzerland 
Embryogen (Medium for Embryo) Origio, Denmark 
Eosin G (Sperm staining) Merck, Germany 
G-1 Plus (Culture medium) Vitrolife, Sweden 
G-2 Plus (Culture medium) Vitrolife, Sweden 
G-IVF Plus (Culture medium) Vitrolife, Sweden 
G-MOPS (Culture medium) Vitrolife, Sweden 
G-TL Plus (Long term culture medium) Vitrolife, Sweden 
SynVitro Hyadase (Denudation) Origio, Denmark 
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Immersion Oil Merck, Germany 
Liquid paraffin Origio, Denmark 
PureSperm 100 (Sperm preperation) Nidacon international AB, Sweden 
PVP clinical grade (Sperm immobilization) Origio, Denmark 
Sodium chloride (NaCl) 0,9% B.Braun, Germany 
Disposables  
1 ml insulin Syringe sterile U-40 BD Medical, USA 
5 ml Syringe sterile B.Braun, Germany 
5 Well culture Dish Vitrolife, Sweden 
Accu-jet pro pipette controller BrandTech Scientific, USA 
Biosphere Filter tips (10-20-200-100 ml) Sarstedt, Germany 
Centre Well Dish Vitrolife, Sweden 
Centrifuge tube (15 ml) Vitrolife, Sweden 
Centrifuge tube (50 ml) Vitrolife, Sweden 
Collection Dish 90mm Vitrolife, Sweden 
Coverslips R. Langenbrinck, Germany 
Culture Dish 40mm Vitrolife, Sweden 
Culture Dish 60mm Vitrolife, Sweden 
Embryo Transfer Catheter Set Cook Medical, USA 
EmbryoSlide culture dish Vitrolife, Sweden 
Flexipet denuding pipette (140 µm, 170 µm, 
300 µm) 
Cook Medical, USA 
Handling micropipettes Origio, Denmark 
Handling pipette for assisted reproduction MTG Medical, Germany 
ICSI micropipettes Origio, Denmark 
IVF ICSI Dish Thermo Scientific Nunc, Denmark 
Microscope Slides R. Langenbrinck, Germany 
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Oocyte collection tube (14 ml) Vitrolife, Sweden 
OOsafe sperm collection cup (80ml) SparMed, Denmark 
Pipettes Eppendorf, Germany 
Serological Pipette (2 ml) Vitrolife, Sweden 
Serological Pipette (5 ml) Sarstedt, Germany 
Spinal needle BD Medical, USA 
Steripette (60 mm) Minitüb, Germany 
Instruments  
Bench-top centrifuge Sigma-Aldrich, Germany 
Binocular light microscope Olympus, Japan 
Blockthermostat Labotect, Germany 
CO2 incubator (C200) Labotect, Germany 
EmbryoScope time-lapse incubator Vitrolife, Sweden 
Heating systems for microscopes Minitüb, Germany 
Heraeus horizontal laminar flow cabinet Heraeus, Germany 
Hot Plate 062 Labotect, Germany 
Incubator C16 Labotect, Germany 
 Inverted microscope: ZEISS Axio Observer ZEISS, Germany 
Makler Counting Chamber Origio, Germany 
Micromanipulation system Narishige, Japan 
Microscope SMZ18 Normal Nikon, Japan 






2.1.3. Reagents, chemicals, kits and equipment in the experimental part 
Reagent or chemical Company 
Absolute Ethanol Merck, Germany 
Agarose tablets (DNase/RNase free) Bioline, UK 
Chromomycin A3 (CMA3) Merck, Germany 
DAPI ( 4′,6-Diamidine-2′-phenylindole 
dihydrochloride) Merck, Germany 
DNA Ladder (10 kb) New England BioLabs, USA 
Ethidium Bromide New England BioLabs, USA 
Glacial acetic acid Fluka, Germany 
Glycerol Merck, Germany 
Methanol Merck, Germany 
Nuclease-free water Qiagen, Germany 
Paraformaldehyde (PFA) 4% in PBS Morphisto, Germany 
Phosphate buffer saline (PBS) Sigma-Aldrich, Germany 
Sodium citrate Merck, Germany 
Tris-Acetate-EDTA buffer (TAE) Sigma-Aldrich, Germany 
Tris-EDTA (TE) Sigma-Aldrich, Germany 
Triton X-100 Sigma-Aldrich, Germany 
β-Mercaptoethanol Merck, Germany 
Kits  
In Situ cell death detection kit, Fluorescein 
(TUNEL) Roche Diagnostics, Germany 
Isolate II RNA/DNA/Protein Kit (Phenol free) Bioline, UK 
miScript II RT kit (Hiflex Buffer) Qiagen, Germany 
MyTaqTMHS RedMix Kit Bioline, UK 
PCR primers (H2BFWT, PRM1, PRM2) MicrosynthSeqLab, Germany 
QuantiTect primer assay (200), GAPDH Qiagen, Germany 
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QuantiTect primer assay (200), H2BFWT Qiagen, Germany 
QuantiTect primer assay (200), PRM1 Qiagen, Germany 
QuantiTect primer assay (200), PRM2 Qiagen, Germany 
QuantiTect primer assay (200), TNP1 Qiagen, Germany 
QuantiTect primer assay (200), TNP2 Qiagen, Germany 
QuantiTect SYBR Green PCR kit Qiagen, Germany 
Instruments  
7500 Fast Real-Time PCR system Applied Biosystems, USA 
Balance Mettler PM200 Mettler Toledo, USA 
Centrifuge CM-6MT ELMI, Latvia 
Consort EV 243 Electrophoresis power supply Sigma-Aldrich, Germany 
EasyCast B2 Mini Gel Electrophoresis System Thermo Scientific, USA 
Eppendorf Bench-top centrifuge Eppendorf, Germany 
Fluorescence Microscope Olympus, Japan 
Freezer, -20°C Liebherr, Germany 
Freezer, -80°C Thermo Scientific, USA 
Freezer, 8°C Liebherr, Germany 
Laboratory timer  Qiagen, Germany 
Light Microscope Carl Zeiss Microscopy, Germany 
Manual counter Karl Hecht "Assistent", Germany 
Microcentrifuge VWR international, USA 
Miniprep PCR-purification HT Qiagen, Germany 
MolecularImager Gel Doc XR & System with 
Image Lab Software Bio-Rad, Germany 
Nanodrop spectrophotometer ND-2000c Thermo Scientific, USA 
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PCR workstation pro (peqlab) VWR international, USA 
Single Read HT Qiagen, Germany 
Thermal Cycler C100 Bio-Rad, Germany 
Thermomixer comfort Eppendorf, Germany 
Vortex-Genie 2 Scientific industries, USA 
Disposables  
96-well PCR Plate 0.2 ml, non-skirted Nippon Genetics Europe, Germany 
Biosphere Filter tips (10-20-200-100 ml) Sarstedt, Germany 
Biosphere plus SafeSeal Micro Tubes (1,5 mL/ 2 
ml) 
Sarstedt, Germany 
Eppendorf Conical Tubes, 15 mL  Eppendorf, Germany 
Flat Cap Strips Nippon Genetics Europe, Germany 
MicroAmp Fast Optical 96-Well Reaction Plate 
with Barcode (0.1ml) 
Applied Biosystems, USA 
Multiply-Pro cup 0.2ml, PP Sarstedt, Germany 
Optical Adhesive Covers (DNA/RNase/Inhibitors 
Free) 
Applied Biosystems, USA 
Parafilm American National Can, USA 
PCR Soft tubes, 0.2 ml (DNA, DNase, RNase free) Biozym, Germany 
Pipettes Eppendorf, Germany 
Racks Sarstedt, Germany 
Single Scale Graduated Cylinders VWR international, USA 











2.2.1. Sperm collection and handling 
The samples were analysed in the IVF laboratory at the department of Obstetrics and 
Gynecology in the Saarland University clinic. 
All samples were collected, by masturbation, after a period of sexual abstinence betwen 
two to five days.  
The specimen container was kept on the heating stage or incubator (37°C) for 30-60 
minutes for liquefaction. Then, macroscopic (ejaculate appearance, viscosity, pH, and 
volume) and microscopic (The spermatozoa concentration, motility, vitality, aggregation, 
and morphology in semen) evaluations were done according to the WHO laboratory manual 
(WHO, 2010) and table 2 illustrated the lower reference limits. 
Table 2: Semen characteristics according to the WHO (2010) 
Parameters (Unit) Reference value 
Semen volume (ml) 1.5 
Total sperm number (106per ejaculate) 39 
Sperm concentration (106 per ml) 15 
Total motility (PR + NP, %) 40 
Progressive motility (PR, %) 32 
Vitality (live spermatozoa, %) 58 
Sperm morphology (normal forms, %) 4 
*PR: progressive motility; NP: non-progressive motility.  
For CMA3 and TUNEL staining, additional semen smears were prepared. 
Before DNA and RNA isolation, the total of semen samples was treated (purification step) 
to remove the cells other than spermatozoa by loading each sample onto 40%–80% 
discontinuous Puresperm gradients (Nidacon International, Sweden) and then centrifuged at 
(500 x g/20 min) at room temperature. 
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2.2.2. Sperm Chromatin condensation assay (Chromomycin A3 assay) 
For the sperm DNA condensation assessment, the Chromomycin A3 (CMA3) assay as 
described previously by Manicardi et al, (1995) was used. CMA3 is aguanine–cytosine-
specific fluorochrome which unveils unwell packaged chromatin in human spermatozoa by 
competing with the protamines for the sameDNA binding sites. 
The first step was the fixation by putting the slides1 hour in glacial acetic acid-methanol 
(1:3) for and then left them to air dry. To each slide, 25µl of CMA3 stain solution was 
added and incubated in the dark for 30 minutes at room temperature (RT). After Wash with 
Phosphate buffer saline (PBS), slides were mounted then kept overnight at 4°C in the dark. 
On each slide, 200 spermatozoa were evaluated using fluorescence Microscope (Olympus, 
Japan): a bright green spermatozoon presents a low protamination state (CMA3 positive) 
and dull green spermatozoa (CMA3 negative) (Figure 10).  
 
Figure 10:  Identification of the sperm chromatin condensation by the chromomycin A3 (CMA3): (1) 
Spermatozoa with condensed chromatin (CMA3 negative) and (2) Spermatozoa with non-condensed 
chromatin (CMA3 positive); (A) Example of non-smoker semen sample and (B) Example of the heavy-






2.2.3. Sperm DNA fragmentation (Terminal deoxyribonucleotidyl transferase-
mediated dUTP nick-end labelling (TUNEL)) 
To assess the fragmentation in the sperm DNA, TUNEL test was used as previously 
described by Borini et al. (2006). The test is based on the quantification of the integrationof 
dUTP at single- and double-strand DNA breaks. This reaction is catalyzed by an enzyme 
terminal deoxynucleotidyl transferase (TdT) provided in the kit of in situ cell death 
detection kit fluorescein (Roche Diagnostics GmbH, Germany). 
The first step is the fixation of smears in slides with 4% paraformaldehyde (Sigma-Aldrich, 
Germany) for two hours at room temperature. Then in the permeabilisation step, the smears 
were incubated for 15 min with 0.1% Triton at RT. To each slide, 25μl of the TdT-labelled 
nucleotide mixture was added then incubated overnight at 37°C in a humidified chamber. 
Then the slides were washed with PBS. After that, 25μl of DAPI (Sigma-Aldrich, 
Germany) was added to each slide as a counterstain. On each slide, 200 spermatozoa were 
evaluated using a fluorescence Microscope (Olympus, Japan). A mixture of exciter 
dichromic barrier filter of BP 436/10: FT 580: LP 470 was used: Green stained 







Figure 11: Identification of the sperm DNA fragmentation by the TUNEL assay: (1) spermatozoa 
without fragmented DNA (TUNEL-negative) and (2) spermatozoa with fragmented DNA (TUNEL-
positive); (A) example of non-smoker semen sample and (B) Example ofthe heavy-smoker semen 
sample. 
2.2.4. Genomic DNA and total RNA purification from semen samples 
Genomic DNA and total RNA were isolated from the purified semen samples according to 
a modified protocol of the Isolate II RNA/DNA/Protein Kit (Phenol-free) (Bioline, UK). 
First, the washing buffers (W1 and W2), Lysis buffer TX and DNase I were prepared as 
follow: 
Wash buffer (W1) Wash buffer W1 concentrate diluted in 90ml 
ethanol (100%) and stored at 25°C 
Wash buffer (W2) Wash buffer W2 concentrate diluted in 15ml 
ethanol (100%) and stored at 25°C 
Lysis buffer TX 10µl β-mercaptoethanol in 1ml buffer TX, stored 
at 25°C 
DNase I (RNase free) 15µl DNase I in 100µl DNase reaction buffer 
(DRB), stored at -20°C 
Then, the lysate was prepared for each sample by adding to each 100µl of the semen 




2.2.4.1. Purification of genomic DNA 
The next steps summarized the protocol for DNA isolation from the semen sample:  
1. The providedDNA column was assembled with thecollection tube 
2. 600µl of the prepared lysate was applied onto the column, thencentrifuged (14,000 x g/ 1 
min) until the total volume passed through. 
3. The flow-through in the collection tube was retained and stored on ice for later total 
RNA isolation. 
4. The column was reassembled with another collection tube. 
5. Genomic DNA in the column was washed two times by applying 500µl of wash buffer 
W1 then 500µl of wash buffer W2 and each time the column was centrifuged (14,000 x g/ 1 
min) and the flow through was discarded. 
6. The column was dried by spin for 2 min at 14,000 x g. 
7. 50µl of DNA elution buffer was applied to the column placed into a fresh elution tube 
and centrifuged first 2 min at 300 x g, then 1 min at 14,000 x g.  
8. The extracted DNA was stored at -80°C for later use. 
2.2.4.2. Purification of total RNA 
The flow-through stored earlier for total RNA purification was processed as follows: 
1. 60µl of 100% ethanol was added to each 100µl of flow-through and mixed by vortex. 
2. The provided RNA column was assembled with thecollection tube and 600µl of lysate 
was applied onto it and centrifuged (3,500 x g/ 1 min). 
3.  Total RNA in the column was washed three times by applying 400µl of wash buffer W1 
and each time the column was centrifuged (14,000 x g/ 1 min) and the flow through was 
discarded. 
4. The column was dried by spin (14,000 x g/ 2 min). 
5. 50µl of RNA elution buffer was applied to the column placed into a fresh elution tube 
and centrifuged first 2 min at 300 x g, then 1 min at 14,000 x g.  
6. The extracted RNA was stored at -80°C for later use. 
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2.2.4.3. Analysis of RNA and DNA concentrations and purity  
The purity and the quantity of the isolated DNA and RNA were checked with the Nanodrop 
spectrophotometer ND-2000c (Thermo Scientific, USA) and they were later held at -80°C 
for later use. The purity of DNA and RNA was assessed by the 260/280 ratio. For pure 
DNA, a ratio equal to 1.8 was accepted and for pure RNA, a ratio equal to 2.0 was 
accepted. The elution buffer was used for the blank measurement.  
2.2.5. Identification of SNPs in the H2BFWT, PRM1 and PRM2 
A standard polymerase chain reaction (PCR) technique was used to amplify the Human 
H2BFWT, PRM1 and PRM2 genes. The primers were designed based on the reference 
sequence for the three candidate genes downloaded from GenBank using Primer3 
(Untergasser et al., 2012) (Table 3). 
Table 3: Primer pairs used for the amplification of H2BFWT, PRM1 and PRM2 gene 
















A 30 µl PCR reaction mixture was prepared using MyTaqTMHS Red Mix Kit (Bioline, UK) 
according to the manufacturer’s instructions:  
DNA template  (20 ng/µl) 
Primers (20µM each) 0.6µl 
MyTaqHS Red Mix, 2x 15µl 




The Thermocycler (C1000TM Thermal cycler, Bio-Rad, United States) program was set as 
follow: 95°C for 3 min, after that40 cycles of 95°C for 20s; annealing temperature for 20s 
(H2BFWT: 64°C ; PRM1 and PRM2: 66°C), extension of 72°C for 1:40 min, thena final 
hold for 1 min at 72°C. To check the amplification, 5 µl of each PCR product for each gene 
was run in a 2% agarose gel mixed with Ethidium Bromide (Biolabs, United States) for 
visualization (EasyCast B2 Mini Gel Electrophoresis System, Thermo Scientific, United 
States) (Figures 12, 13 and 14). 
The rest of the PCR products were purified with Miniprep PCR-purification HT (Qiagen, 
Germany) and sequenced using the Sanger sequencing technique and 2 single Read HT 
(Qiagen, Germany) were made for each gene. 
 
Figure 12: Representative gel electrophoresis on agarose gel (2%) of PCR products for the 
amplification of the H2BFWT gene (1.46 Kb). Lane M: DNA Ladder (0.1-10.0 kb) (NE Biolabs, USA), 
Lane 1-8: PCR samples products. The Fragments of DNA were separated onan electric field of 70 V/ 90 
min. For the visualization of the gel after DNA migration, the Molecular Imager® Gel Doc™ XR& 
System with Image Lab™ Software (BIO-RAD, USA) were used.  
 
 









Figure 13: Representative gel electrophoresis on agarose gel (2%) of PCR products for the 
amplification of the PRM1 gene (0.71 Kb). Lane M: DNA Ladder (0.1-10.0 kb) (NE Biolabs, USA), 
Lane 1-8: PCR samples products. The Fragments of DNA were separated on an electric field of 70 V/ 
90 min. For the visualization of the gel after DNA migration, the Molecular Imager® Gel Doc™ XR& 










Figure 14: Representative gel electrophoresis on agarose gel (2%) of PCR products for the 
amplification of the PRM2 gene (0.88 Kb). Lane M: DNA Ladder (0.1-10.0 kb) (NE Biolabs, USA), 
Lane 1-8: PCR samples products. The Fragments of DNA were separated on an electric field of 70 V/ 
90 min. For the visualization of the gel after DNA migration, the Molecular Imager® Gel Doc™ XR& 
System with Image Lab™ Software (BIO-RAD, USA) were used.  
2.2.6. Reverse transcription and quantitative PCR (RT-qPCR) 
RT-qPCR technique was used for the quantification of the expression level of the five 
studied genes:H2B histone family member W, testis-specific (H2BFWT), transition protein 
1 (TNP1), transition protein 2 (TNP2), protamine 1 (PRM1), protamine 2 (PRM2), and the 
reference gene Glyceraldehyde 3-phosphate dehydrogenase (GAPDH). 
The extracted sperm RNA was converted into cDNA in a 20µl reaction volume via 
miScript reverse transcription kit (Qiagen, Germany), following the kit recommendations: 
1. The isolated RNA (250-300 ng) was mixed with 4µl of miScript HiFlex Buffer (5x), 2µl 
of miScript Reverse transcriptase mix, 2µl of miScript nucleic mix and RNase free water 
until 20µl. 
2. The mix was incubated in a thermocycler for 60 min at 37° C, then 5 min at 95°C to 
inactivate the transcriptase mix.  








3. The purity and quantity of cDNA was determined with Nanodrop spectrophotometer 
ND-2000c (Thermo Scientific, USA)  
4. The cDNA was held at -20°C for later use. 
QuantiTect SYBR Green PCR Kit (Qiagen, Germany) was usedfor real-time quantitative 
PCR 
A 96 well block real-time cycler (7500 Fast Applied Biosystems, United States) was used 
to measure the emitted fluorescence during the binding of the SYBR Green to double-
stranded DNA molecules.  
Then, according to the manufacturer's recommendations, the cDNA was used as a template 
to prepare along with QuantiTect primer assay (Qiagen, Germany) a PCR reaction plate 
mix as follow: 
1. For each sample, a reaction mixes of 10µl SYBR Green, 2 µl of QuantiTect primer assay 
(for each studied gene) and 6µl of RNase free water were prepared and added into a well of 
MicroAmp Fast Optical 96-Well Reaction Plate with Barcode (Applied Biosystems, United 
States) 
2. A 2µl of undiluted cDNA was added to this mix in the well. 
3. Each sample was run in triplicate and no template control and no reverse transcriptase 
control were included in each run.  
4. With an optical adhesive cover (Applied Biosystems, United States), the plate was closed 
and put in a centrifuge (1500 rpm/ 1 minute) to spin the mix down and eliminate air 
bubbles. 
5. The plate was placed in the Applied Biosystems 7500 and the cycling program was: 
Initial activation (95°C for 15 min), after that3 step cycling (Denaturation (94°C for 15 s), 
annealing (55°C for 30 s) and extension (72°C for 15 s) for 40 cycles. 
6.  Data from real-time PCR are Ct or threshold cycles which refer to the cycle number at 
which detectable signal is achieved.  
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2.2.7. Protocol of embryo culture and Time-Lapse Imaging 
After 3-4 hours of oocytes retrieval, a decoronation of the cumulus-corona oocyte cell 
complex was performed using hyaluronidase (SynVitro Hyadase, Origio, Denmark) and the 
intracytoplasmic sperm injection (ICSI) is effectuated onoocytes in metaphase II stage 
using a micromanipulation system (Narishige, Japan) and an inverted microscope (Zeiss, 
Germany) (Figure 15). 
 
Figure 15: Intracytoplasmic sperm injection (ICSI) Day; (a) A cumulus-corona oocyte cell complex, (b) 
Denuded Metaphase II (MII) Oocyte. 
For embryo culture and assessment, the microdrop culture system and the Embryo Scope 
time-lapse incubator (Vitrolife, Sweden) were used. After injection, the oocytes were 
distributed in an Embryo Slide culture dish (Vitrolife, Sweden) that can hold 12 embryos. 
In each well of the dish, 25 µl of global total culture medium (Life Global, Canada) was 
added. The incubation conditions were: Temperature = 37°C, 5.5% Oxygen (O2) and 5.5% 
carbon dioxide (CO2). 
The embryo quality grade was assessed on day 3 after injection (Cleavage stage) according 
to the division symmetry, cytoplasmic fragmentation proportion (Grade 1: 0-10% of 
cytoplasm fragmented, Grade 2: 11-20% of cytoplasm fragmented, grade 3: >20 of 
cytoplasm fragmented) (Depa-Martynow et al., 2012) using the EmbryoViewer Software 




Figure 16: Embryo cleavage stages after ICSI; (a) Fertilized oocyte (Zygote) with two polar bodies and 
two central equal pronuclei (PNs) (18h post-ICSI), (b): A 2-blastomeres human embryo (Day 1 post-
ICSI), (c): A 4-blastomeres human embryo (Day 2 post-ICSI), (d): A 8-blastomeres human embryo 
(Day 3 post-ICSI). 
Also, the embryo quality is assessed on day 4 (Morula stage) (Figure17) and day 5 
(Blastocyst stage) using Gardner’s blastocyst grading scaleincluding expansion, inner cell 
mass (ICM) and Trophectoderm Epithelium (TE) (Gardner et al., 2007) (Figure 18). 
 
Figure 17: Progressive compaction of the human embryo on day 4 post-ICSI leading to the formation of 
morula. 




Figure 18: Blastocyst formation (Day 4-5 post-ICSI); (a) Human embryo with early cavitation, (b) 
Early blastocyst, (c) Expanded blastocyst. 
In 30% of cases, the embryo is transferred in the cleavage stage and in 70% in the 
blastocyst stage. The average of embryo transfer is 2 embryos/ patient. 
2.2.8. Statistical Analysis 
IBM SPSS for Windows software package version 24.0 (SPSS Inc., USA) was used to 
analyse the data obtained in the current study. After application of the skewness test, 
Kurtosis test, Z-value and Shapiro test, it has been demonstrated that the samples were 
notnormally distributed. Thus, for the comparison of the quantitative variables between the 
heavy-smokers and non-smokers groups, the Mann- Whitney U-test was used and the 
Spearman correlation test was applied to determine the correlation between the different 
studied parameters. The p-value≤0.05 was interpreted as statistically significant and p<0.01 
was interpreted as statistically highly significant.  
For the analysis of the real-time qPCR data, the relative quantification, based on the use of 
a reference gene, was used. The relative amount of each gene mRNA to the GAPDH gene 
was determined by the Livak or ∆∆Ct method (Livak & Schmittgen, 2001). The protamine 
PRM1: PRM2 mRNA ratio was calculated as described previously by Steger et al., 2003.  
The tool Tracy (https://github.com/gear-genomics/tracy) was used to obtain the allelic 
sequences for each gene. The aligner bwa (Li & Durbin, 2009), the samtools mpileup (Li et 
al., 2009) and WhatsHap (Ebler et al., 2018, Patterson et al., 2015) were used for the 
variant calling. From the set of all SNPs resulting from the previous steps, all positions with 
an allele frequency above 5 % across all studied individuals were selected and tested for 
Hardy-Weinberg Equilibrium using Fisher's Exact Test. To test the association between 
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SNP alleles and each of the studied groups of heavy smokers and non-smokers, Fisher's 
Exact Test was performed to find significant differences in allele distributions among the 
two groups (Heavy-smokers and non-smokers) and corrected for multiple testing by 






















3.1. Investigated parameters for all study patients 
Table 4: Descriptive statistic of studied parameters for all the population undergoing ICSI 
therapy (N=167) 
Parameters M ± SD Median  Mini-Max 
Semen volume (ml) 3.26 ± 1.54 3.00   0.7 - 9.0 
Sperm concentration (106x1 
ml) 70.56 ± 56.87 56.00  1.0 - 286.0 
Total motility  
(PR + NP. %) 
42.26 ± 20.46 44.00  2 - 91 
Progressive motility  
(PR. %) 
18.89 ± 16.32 16.00  0 - 80 
Morphologically normal 
spermatozoa (%) 6.23 ± 7.93 4.00   0 - 53 
Protamine deficiency 
(CMA3 positivity) (%) 
30.30 ± 19.96 25.50   0 - 98 
Sperm DNA fragmentation 
(sDF)(%) 24.25 ± 18.99 20.00   0 - 97 
Number of collected oocytes 11.72 ± 6.82 12.00   1 - 37 
Number of injected oocytes 8.81 ± 5.42 8.00  1- 24 
Number of fertilized oocytes 6.91 ± 4.62 6.00   0 - 22 
Fertilization rate (%) 77.75 ± 20.46 83.17   0 - 100 
Number of cleaved embryos 6.60 ± 4.47 5.00   0 - 20 
Number of grade 1 embryos 
(G1)  2.23 ± 2.53 2.00  0 - 13 
Number of grade 2embryos 
(G2)   2.79 ± 2.36 2.00  0 - 14 
Embryos grade score 1.88 ± 0.56 2.00  0 - 4 
M: mean; Mini: minimum; Max: maximum; SD: standard deviation 
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Table 4 illustrates the descriptive statistics: mean ± standard deviation, median, and 
minimum-maximum of the different studied parameters. The mean of the sperm 
parameters: semen volume (ml), sperm concentration (106 per ml), total motility (PR + NP. 
%), progressive motility (PR. %), and morphologically normal spermatozoa (%) were (3.26 
± 1.54; 70.56 ± 56.87; 42.26 ± 20.46; 18.89 ± 16.32; 6.23 ± 7.93 respectively). 
For those patients where the protamine deficiency (CMA3 positivity) was determined by 
CMA3 staining it ranged between 0 and 98% with a mean of 30.30 ± 19.96%, and the 
sperm DNA fragmentation (sDF), determined by a TUNEL assay, it was in the range (0-97) 
with a mean of 24.25 ± 18.99%.  
Concerning the clinical parameters after ICSI, the mean number of collected oocytes was 
11.72 ± 6.82, injected oocytes was 8.81 ± 5.42, and fertilized oocytes was 6.91 ± 4.62. The 
fertilization rate has a mean of 77.75 ± 20.46%. 
The mean number of grade 1 (G1) and 2 (G2) embryos ranged between 0 and 14 and their 
mean percentage together (G1+G2) was 77.54 ± 27.57%. The mean of the embryos grade 












Table 5: Comparison of the semen analysis parameters between control group (non-










3.56 ± 1.76 3.12 ± 1.40 0.325 
Sperm 
concentration 
(106 x1 ml) 
 
88.09 ± 63.42 
 
 




(PR + NP. %) 









10.87 ± 12.11 4.01 ± 2.88 0.002** 
M: mean; n: Number; SD: standard deviation 
The ICSI patients were divided into the following two groups: a control group (non-
smokers, n=54) and a case group (heavy-smokers, n= 113). 
By comparing the classical semen parameters between these two investigated groups, the 
mean percentage of sperm concentration, progressive motility (PR), and morphologically 
normal spermatozoa were significantly elevatedin the non-smokers group (p= 0.009, 
p=0.001, and p=0.002 respectively) (Table 5). 
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Table 6: Comparison of the grade of protamine deficiency in sperm DNA (CMA3 
positivity) and sperm DNA fragmentation (sDF) between the control group (non-smokers) 














17.41 ± 14.59 27.55 ± 20.01 0.0001** 
M: mean; n: Number; SD: standard deviation 
Protamine deficiency (CMA3 positivity) and sperm DNA fragmentation (sDF) were 
significantly higher in the heavy-smokersgroup in comparison to the non-smokersgroup 
(33.58 ± 21.34% vs.23.50 ± 14.70%, p=0.003 and 27.55 ± 20.01% vs. 17.41 ± 14.59%, p= 









Table 7: Comparison of the ICSI-outcomes between the control group (non-smokers) and 
















9.00 ± 5.86 
 
 










6.64 ± 4.71 6.58 ± 4.37 0.908 
Fertilization 
rate (%) 
77.96 ± 19.30 
 









2.45 ± 2.29 2.94 ± 2.38 0.140 
Embryos 
grade score 
1.98 ± 0.60 1.84 ± 0.53 0.450 
M: mean; n: Number; SD: standard deviation 
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The clinical data of patients who had had ICSI therapy and whose husbands were heavy-
smokers (n=113) and non-smokers (n= 54) showed no significant difference. The mean 
number of collected, injected, fertilized oocytes and the fertilization rate were similar in 
both investigated groups. In addition, the mean of the grade 1 embryos, the grade 2 
embryos and the embryos grad score did not differ significantly from each other (Table 7). 
3.2. The study of the gene expression level of H2BFWT, PRM1, PRM2, TNP1 
and TNP2 
3.2.1. The characteristic of the study population 
141 samples out of 167were used for the evaluation of the gene expression levels of some 
of the key nuclear proteins in the sperm chromatin remodelling: H2BFWT, TNP1, TNP2, 
PRM1, and PRM2 in order to identify their correlation to the classical sperm parameters 
and ICSI outcomes using two of the common tests of the sperm’s chromatin integrity, 















Table 8: Descriptive statistics of studied parameters for the gene expression study patients 
(n=141) 
Parameters M± SD Median  Mini-Maxi 
Semen volume (ml) 3.33 ± 1.57 3.00  0.70 - 9.00 
Sperm concentration (106 
per ml) 
79.03 ± 59.68 63.00  2.00 - 286.00 
Total motility (PR + NP 
%) 
42.80 ± 20.999 44.00  2.00 - 91.00 
Progressive motility (PR 
%) 
20.55 ± 17.17 17.00  0 - 80.00 
Morphologically normal 
spermatozoa (%) 
6.94 ± 8.40 4.00  0 - 53.00 
Protamine deficiency 
(CMA3 positivity) (%) 
29.35 ± 20.86 24.00  0 - 98 
Sperm DNA 
fragmentation (sDF)(%) 
22.89 ± 18.85 15.00 0 - 97 
Fertilization rate (%) 79.04 ± 19.85 83.00  0 - 100 
Number of cleaved 
embryo 
6.65 ±  4.74 5.00  0 - 24.00 
Number of grade 
1embryos (G1) 
2.34± 2.56 2.00  0 - 13.00 
Number of grade 
2embryos (G2) 
2.83±2.48 2.00  0 - 14.00 
Embryos grade score 1.87±0.56 1.94  0 - 4.00 
Pregnancy rate (%) 0.45 ± 0.5 - - 
M: mean;Mini: minimum; Max: maximum; SD: standard deviation 
Table 8 provides a summary of the statistical analysis of the sperm parameters, protamine 
deficiency, sperm DNA fragmentation, and ICSI outcomes. The means ± SD of the sperm 
volume was 3.33 ± 1.57 (ml), sperm concentration was 79.03 ± 59.68 (106/ml), total 
motility was 42.80 ± 20.99%, progressive motility was 20.55 ± 17.17%, and 
morphologically normal spermatozoa was 6.94 ± 8.40%.  
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The CMA3 positivity ranged between 0 and 98% and had a mean value of 29.35 ± 
20.86%.The sDF ranged between 0 and 97% and had a mean of 22.89±18.85%. 
The fertilization rate was 79.04 ± 19.85%. The number of cleaved embryos ranged between 
(0-24), grade 1 embryos (G1) ranged between (0-13), and grade 2 embryos (G2) ranged 
between (0-14). The mean embryos grade score was 1.87 ± 0.56 and the mean percentage 
of pregnancy rate was 0.45 ± 0.5%. 
Table 9: Descriptive statistic of the expression level (Delta Ct (∆Ct)) of the studied genes 
for all the investigated patients (n=141) in the gene expression study 
Parameters M± SD Median Mini-Max 
 ∆Ct H2BFWT 12.51±4.75 12.43  1.55 - 23.52 
 ∆Ct TNP1 0.80±2.04 1.48  -4.87 - 4.35 
∆Ct TNP2 8.33±5.56 8.20  -32.09 - 20.00 
∆Ct PRM1 0.26±2.42 0.55  -6.38 - 7.39 
∆Ct PRM2 0.71±2.86 1.00  -5.58 - 9.85 
Protamine (P1-P2) 
mRNA ratio   
0.45±1.04 0.54 -2.88 - 4.78 
M: mean; Mini: minimum; Max: maximum; SD: standard deviation  
The relative quantification of each gene of interest expression (H2BFWT, TNP1, TNP2, 
PRM1 and PRM2) was done by performing the normalized expression analysis method and 
indicated by delta Ct value (∆Ct). The reference gene was the GAPDH and the non-
smokers group was the control group. 
Table 9 represents the mean ± standard deviation, the median, minimum and maximum of 
the relative mRNA amount of the 5 studied genes. For the H2BFWT gene, the mean ± SD 
was 12.51 ± 4.75. For TNP1 and TNP2, the expression level means were 0.80 ± 2.04 and 
8.33 ± 5.56 respectively. Besides, the delta Ct mean value ± SD for protamin1 gene was 
0.26 ± 2.42 and for protamine 2 was 0.71 ± 2.86. The Protamine mRNA ratio (P1-P2) has a 
mean value of 0.45 ± 1.04. 
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3.2.2. Non-smokers versus heavy-smokers 
The patients were later divided according to smoking status into two groups: A group of 
non-smokers (n=43) and a group of heavy-smokers (n=98). 
Table 10: Comparison of the semen analysis parameters between the control group (non-




M ± SD 
Heavy-smokers (n=98) 




3.71 ± 1.76 3.17 ± 1.46 0.181 
Sperm 
concentration 
(106 per ml) 
 
98.56 ± 64.63 
 
 




(PR + NP. %) 









12.91 ± 12.76 4.32 ± 2.93 0.0001** 
M: mean; n: Number; SD: standard deviation 
By comparing the semen parameters between the two groups (Table 10), we found that the 
mean concentration and the total motility were significantly elevatedin the group of non-
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smokers (p=0.014, and p= 0.026 respectively) and similarly noticed for the mean percent of 
the progressive motility and normal morphology (p= 0.0001).  
Table 11: Comparison of the grade of protamine deficiency (CMA3 positivity) in sperm 
DNA and sperm DNA fragmentation (sDF) between the control group (non-smokers) and 







CMA3 positivity (%) 20.35 ± 13.43 33.30 ± 22.33 0.001** 
Sperm DNA 
fragmentation (sDF)(%) 
14.23 ± 13.07 26.68 ± 19.77 0.0001** 
M: mean; n: Number; SD: standard deviation 
Furthermore, the mean percentage of CMA3 positivity in the group of non-smokers was 
significantly lower in comparison to heavy-smokers (20.35 ± 13.34 vs. 33.30 ± 22.33, 
p=0.001). The mean percentage of sDF revealeda marked difference between the non-











Table 12: Comparison of the ICSI-outcomes between the control group (non-smokers) and 














6.70 ± 4.75 6.63 ± 4.76 0.923 
Number of 
grade 1 
embryos (G1)  
2.67 ± 2.93 2.19 ± 2.39 0.567 
Number of 
grade 2 
embryos (G2)   
2.49 ± 2.31 2.98 ± 2.55 0.195 
Embryos 
grade score 
1.99 ± 0.61 1.82 ± 0.54 0.229 
Pregnancy 
rate (%) 
0.60 ± 0.49 0.38 ± 0.48 0.013** 
M: mean; n: Number; SD: standard deviation 
Moreover, except for the pregnancy rate, which was significantly elevatedin the group of 
non-smokers than in the heavy-smokers group (p=0.013), there were no significant 
dissimilarities in the other investigated parameters, namely, fertilization rate, number of 
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cleaved embryos, number of grade 1 (G1), grade 2 (G2) embryos and the embryo grade 
score, between the two groups (Table 12). 
Table 13: Comparison of the mRNA relative amount of the studied genes between the 






M ± SD 
Heavy-smoker (n=98) 
M ± SD 
P-value 
H2BFWT 10.75 ± 4.90 13.35 ± 4.45 0.001** 
TNP1 -0.04 ± 1.954  
1.17 ± 1.98 0.001** 
TNP2 5.61 ± 7.54  
9.52 ± 3.92 0.0001** 
PRM1 -0.64 ± 2.248  
0.66 ± 2.41 0.002** 
PRM2 -0.53 ± 2.61  
1.25 ± 2.82 0.001** 
Protamine 
(P1–P2) 
mRNA ratio   
0.11 ± 0.84  0.60 ± 1.08 0.001** 
M: mean; n: Number; SD: standard deviation 
The relative amounts of the investigated genes mRNA (mean delta ct) (H2BFWT, TNP1, 
TNP2, PRM1, and PRM2) were differentially expressed between the compared groups. 
This difference between the group of heavy smokers and the group of non-smokers was 
highly significant (p<0.01) (Table 13). Furthermore, the protamine mRNA ratio was also 
significantly elevatedin the case group in comparison to the control group (0.60 ± 1.08 vs. 






Table 14: Mean expression levels (delta Ct) of H2BFWT, TNP1, TNP2, PRM1 and PRM2 
genes from spermatozoa in the case group (heavy-smokers) compared to control group 
(non-smokers) 
Genes 
Mean delta Ct 
Non-smokers 










H2BFWT 10.75 13.35 0.16 -2.6 Down 
TNP1 -0.04 1.17 0.43 -1.21 Down 
TNP2 5.61 9.52 0.06 -3.91 Down 
PRM1 -0.64 0.66 0.40 -1.3 Down 
PRM2 -0.53 1.25 0.29 -1.78 Down 
 
Since the correlation between delta Ct (∆Ct) and the gene expression level is contradictory, 
the higher delta Ct values indicate that the gene expression is decreased. This was 
demonstrated in table 14 where the H2BFWT, TNP1, TNP2, PRM1 and PRM2 were 












3.2.3. Correlation between the investigated sperm parameters and ICSI outcomes 

















































































Semen volume (ml) 
r -0.012 -0.112 -0.160 -0.031 0.035 
p 0.904 0.271 0.115 0.760 0.735 
Sperm 
concentration 
 (106 per ml) 
r 0.033 -0.075 -0.027 -0.082 -0.018 
p 0.744 0.465 0.790 0.427 0.860 
Total motility  
(PR + NP. %) 
r 0.035 -0.078 -0.138 0.008 -0.121 
p 0.729 0.444 0.175 0.940 0.237 
Progressive 
motility (PR. %) 
r 0.071 -0.002 -0.079 0.114 -0.049 




r 0.174 0.049 -0.103 0.123 0.023 
p 0.087 0.631 0.315 0.231 0.823 
 
In the heavy-smokers group, the ejaculate volume, sperm concentration, motility and 
morphologically normal spermatozoa showed no correlation with the ICSI outcomes 
(fertilization rate, number of cleaved, grade 1 (G1) and, grade 2 (G2) embryos and, the 


























































































Semen volume (ml) 
r -0.092 -0.033 0.006 -0.110 0.019 
p 0.556 0.834 0.969 0.482 0.905 
Spermconcentration 
 (106 per ml) 
r -0.083 -0.088 -0.154 0.010 0.166 
p 0.598 0.576 0.324 0.948 0.288 
Total motility  
(PR + NP. %) 
r -0.064 -0.522** -0.391** -0.511** 0.338* 
p 0.685 0.0001 0.009 0.0001 0.027 
Progressive motility 
(PR. %) 
r 0.081 -0.584** -0.425** -0.585** 0.351* 





r 0.209 -0.535** -0.447** -0.433** 0.368* 
p 0.178 0.0001 0.003 0.004 0.015 
 
On the contrary, for the non-smokers group (Table 16), the mean value of cleaved embryos 
correlated as being negatively significant (p=0.0001) with the mean percentage of sperm 
parameters: total motility (r=-0.522), progressive motility (r=-0.584), and morphologically 
normal spermatozoa) (r=-0.535). Moreover, similar correlations were observed between the 
same parameters (total motility, progressive motility, and morphologically normal 
spermatozoa) and the number of grade 1embryos (r=-0.391, p=0.009; r=-0.425, p=0.004; 
r=-0.447, p=0.003 respectively), the number of grade 2 embryos (r=-0.511, p=0.0001; r=-
0.585, p=0.0001; r=-0.433, p=0.004 respectively). Moreover, the embryos grade score 
correlated positively with the investigated sperm parameters (Total motility progressive 
motility and morphologically normal spermatozoa) (r=0.338, p=0.027; r=0.351, p=0.021; 




3.2.4. Correlation between the different sperm parameters, protamine deficiency and 
sperm DNA fragmentation 
Table 17: Correlation between the investigated sperm parameters, protamine deficiency 








































































































r 1.000 -0.042 0.004 -0.024 0.097 -0.117 -0.029 
p 
 
0.681 0.965 0.812 0.343 0.251 0.776 
Sperm 
concentration 
(106 per ml) 
r -0.042 1.000 0.294** 0.515** 0.531** -0.233* -0.263** 
p 0.681 
 
0.003 0.0001 0.0001 0.021 0.009 
Total motility 
(PR + NP. %) 
r 0.004 0.294** 1.000 0.677** 0.439** 0.133 0.101 
p 0.965 0.003 
 




r -0.024 0.515** 0.677** 1.000 0.583** -0.097 -0.063 
p 0.812 0.0001 0.0001 
 





r 0.097 0.531** 0.439** 0.583** 1.000 -0.140 -0.177 




positivity  (%) 
r -0.117 -0.233* 0.133 -0.097 -0.140 1.000 0.484** 
p 0.251 0.021 0.193 0.340 0.169 
 
0.0001 
In the heavy-smokers group (Table 17), the mean percentage of the sperm concentration 
correlated positively with the mean percentages of total motility (r= 0.294, p= 0.003), 
progressive motility (r=0.515, p= 0.0001), and morphologically normal spermatozoa 
(r=0.531, p= 0.0001) and correlated negatively with the protamine deficiency (r=-0.233, 
p=0.021) and the sDF (r=-0.263, p=0.009). The total and progressive motility showed a 
high positive correlation with the mean of morphologically normal spermatozoa (r=0.439, 
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r=0.583 respectively; p=0.0001). In addition, a significant correlation (r= 0.484, p=0.0001) 
between CMA3 positivity and sDF was shown (Table 17). 
Table 18: Correlation between the different sperm parameters, protamine deficiency 










































































































r 1.000 -0.338* 0.184 0.242 0.227 0.147 -0.113 
p 
 
0.027 0.237 0.117 0.142 0.345 0.469 
Sperm 
concentration 
 (106 per ml) 
r -0.338* 1.000 0.159 0.107 0.110 -0.240 -0.297 
p 0.027 
 
0.309 0.494 0.481 0.121 0.053 
Total motility 
(PR + NP. %) 
r 0.184 0.159 1.000 0.874** 0.663** 0.037 -0.304* 
p 0.237 0.309 
 




r 0.242 0.107 0.874** 1.000 0.830** 0.018 -0.304* 
p 0.117 0.494 0.0001 
 





r 0.227 0.110 0.663** 0.830** 1.000 -0.146 -0.361* 





r 0.147 -0.240 0.037 0.018 -0.146 1.000 0.256 
p 0.345 0.121 0.815 0.907 0.350 
 
0.098 
Table 18 illustrates the correlations between the mean percentage of the different sperm 
parameters, the protamine deficiency (CMA3 positivity) and sperm DNA fragmentation 
(sDF) in the non-smokers group. The semen volume correlated negatively with the 
concentration (r=-0.338, p=0.027) and the mean percentage of total motility correlated 
positively with the mean percentage of morphologically normal spermatozoa (r=0.663, 
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p=0.0001) and negatively with the mean percentage of sDF (r=-0.304, p=0.048). In 
addition, the progressive motility correlated positively with morphologically normal 
spermatozoa (r=0.830, p=0.0001) and negatively with the mean percentage of sDF (r=-
0.304, p=0.047). In addition, the mean percentage of morphologically normal spermatozoa 
showed a significant negative correlation with the mean percentage of sDF (r=-0.361, 
p=0.017). 
3.2.5. Correlation between protamine deficiency, sperm DNA fragmentation and ICSI 
results 
Table 19: Correlation between protamine deficiency (CMA3 positivity), sperm DNA 
fragmentation (sDF) and ICSI results in the non-smokers group (n=43) 






of grade 1 
embryos 
Number 





CMA3 positivity  
(%) 
r 0.039 -0.037 0.186 -0.235 -0.107 
p 0.805 0.813 0.232 0.130 0.496 
sDF (%)  
r 0.077 0.394
** 0.341* 0.316* -0.045 
p 0.624 0.009 0.025 0.039 0.773 
 
In the non-smokers group (Table 19), the mean percentage of the sperm DNA 
fragmentation correlated positively with the number of cleaved embryones (r=0.394, 
p=0.009), number of grade 1 (r=0.341, p=0.025), and number of grade 2 embryos (r=0.316, 






Table 20: Correlation between protamine deficiency (CMA3 positivity), sperm DNA 
fragmentation (sDF) and ICSI results in the heavy-smokers group (n=98) 






of grade 1 
embryos 
Number 







r 0.152 0.082 0.009 0.061 0.145 
p 0.135 0.421 0.929 0.550 0.153 
sDF (%)  
r 0.050 0.117 0.086 -0.007 0.034 
p 0.625 0.252 0.402 0.946 0.736 
 
Table 20 showed that in the heavy-smokers group, neither the mean percent of CMA3 















3.2.6. Correlation between the expression levels of the different studied genes and 
sperm parameters 
Table 21: Correlation between the mRNA relative amount of the studied genes and sperm 









(106 per ml) 
Total 
motility (PR 










r -0.142 -0.035 -0.062 -0.146 -0.143 
p 0.363 0.821 0.693 0.352 0.362 
∆Ct PRM2 
 
r -0.197 -0.036 -0.072 -0.164 -0.166 
p 0.205 0.817 0.645 0.293 0.288 
∆Ct TNP1 r -0.184 0.079 -0.044 -0.175 -0.241 
p 0.237 0.615 0.778 0.262 0.119 
∆Ct TNP2 r -0.176 0.064 0.013 -0.077 -0.120 
p 0.290 0.704 0.937 0.645 0.473 
∆Ct 
H2BFWT 
r -0.177 -0.075 0.179 0.251 0.150 
p 0.274 0.644 0.270 0.119 0.356 
Protamine 
(P1–P2) 
mRNA ratio  
r -0.463** 0.100 -0.036 -0.108 -0.180 
p 0.002 0.525 0.820 0.489 0.248 
 
Table 21 shows that in the non-smokers group none of the investigated spermatozoa 
parameters (Semen volume, sperm concentration, total motility, progressive motility, and 
morphologically normal spermatozoa) correlates with the relative expression levels (∆Ct) 
of the PRM1, PRM2, TNP1, TNP2 and H2BFWT. However, the protamine mRNA ratio 
had a significant negative correlation with the semen volume (r=-0.463, p=0.002).  
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Table 22: Correlation between the mRNA relative amount of the studied genes and sperm 








(106 per ml) 
Total 
motility 











r -0.008 0.335** 0.203* 0.337** 0.214* 
p 0.940 0.001 0.045 0.001 0.035 
∆Ct PRM2 
 
r -0.028 0.329** 0.187 0.338** 0.166 
p 0.782 0.001 0.066 0.001 0.103 
∆Ct TNP1 
 
r -0.076 0.391** 0.238* 0.361** 0.294** 
p 0.458 0.0001 0.018 0.0001 0.003 
∆Ct TNP2 
 
r -0.027 0.369** 0.197 0.359** 0.303** 
p 0.805 0.0001 0.067 0.001 0.004 
∆Ct 
H2BFWT 
r -0.135 0.058 0.064 0.230* 0.084 





r -0.073 0.012 0.228* 0.128 -0.030 
p 0.478 0.910 0.024 0.210 0.771 
 
In the heavy-smokers group (Table 22), the mean of the relative protamine 1 (PRM1)  and 
transition protein 1 (TNP1) level correlated positively with the sperm concentration 
(r=0.335, p= 0.001 ; r=0.391, p= 0.0001 respectively), total motility  (r=0.203, p= 
0.045;r=0.238, p= 0.018 respectively), progressive motility (r=0.337, p=0.001; r=0.361, 
p=0.0001respectively), and morphologically normal spermatozoa (r=0.214, p=0.035; 
r=0.294, p=0.003 respectively), while the expression level of PRM2 showed a significant 
positive correlation with the sperm count (r=0.329, p=0.001) and the progressive motility 
(r=0.338, p=0.001).  
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The mean of the relative expression level of TNP2 showed a high positive correlation with 
the mean of the sperm count, the mean percentage of the progressive motility and the 
morphologically normal sperm form (r=0.369, p=0.001; r=0.359, p=0.001; r=0.303, 
p=0.004 respectively) (Table 22). 
Besides, significant positive correlations between the relative amount of H2BFWT mRNA 
and the mean percent of sperm with progressive motility (r=0.230, p=0.027) and between 
the protamine mRNA ratio and the mean percent of total motility (r=0.228, p=0.024) were 
found (Table 22). 
3.2.7. Correlation between the investigated gene expression levels and clinical 
parameters after ICSI 
Table 23: Correlation between the mRNA relative amount of the studied genes and clinical 


















r -0.281 -0.258 -0.401** -0.310 0.011 0.002 
p 0.068 0.094 0.008 0.058 0.948 0.988 
Number of 
cleaved embryos 
r 0.070 0.064 0.095 0.005 -0.253 0.046 
p 0.654 0.682 0.543 0.976 0.115 0.771 
Number of grade 
1 embryos (G1) 
r -0.053 -0.045 -0.105 -0.106 -0.168 0.085 
p 0.733 0.776 0.504 0.526 0.301 0.589 
Number of grade 
2 embryos (G2) 
r 0.159 0.158 0.204 0.113 -0.190 0.078 
p 0.310 0.313 0.189 0.499 0.241 0.617 
Embryos grade 
score 
r 0.092 0.068 0.132 0.035 0.170 -0.100 




In all the investigated parameters there was no significant correlation between the relative 
expression levels of PRM1, PRM2, TNP1, TNP2 and H2BFWT genes and clinical 
parameters after intracytoplasmic sperm injection (ICSI). However, the relative amount of 
the TNP1 mRNA correlated negatively with the fertilization rate (r=0.401, p=0.008) in the 
non-smokers group (Table 23).  
Table 24: Correlation between the mRNA relative amount of the studied genes and ICSI 


















r 0.043 0.081 -0.014 0.093 0.086 0.195 
p 0.675 0.427 0.894 0.393 0.413 0.055 
Number of 
cleaved embryos 
r -0.043 -0.013 -0.120 -0.021 0.003 -0.016 
p 0.674 0.898 0.240 0.849 0.979 0.878 
Number of grade 
1 embryos (G1) 
r -0.059 -0.083 -0.051 -0.008 0.002 -0.135 
p 0.564 0.416 0.619 0.943 0.987 0.185 
Number of grade 
2 embryos (G2) 
r 0.109 0.105 -0.002 0.085 0.052 -0.048 
p 0.288 0.307 0.985 0.436 0.619 0.641 
Embryos grade 
score 
r 0.110 0.119 -0.003 0.052 -0.119 0.047 
p 0.282 0.244 0.979 0.636 0.256 0.647 
 
Furthermore, no correlations were observed between the clinical parameters after ICSI 
(fertilization rate, number of cleaved embryos, number of grade 1 embryos, number of 
grade 2 embryos, embryos grade score) and the relative expression levels of H2BFWT, 
TNP1, TNP2,PRM1, and PRM2 genes in the heavy-smokers group (Table 24). 
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3.2.8. Correlation between the expression levels of the investigated genes and 
protamine deficiency (CMA3 positivity) and sperm DNA fragmentation (sDF) 
Table 25: Correlation between the mRNA relative amount of the studied genes, protamine 
deficiency (CMA3 positivity) and sperm DNA fragmentation (sDF) in the control group 
(non-smokers, n=43) 
  
CMA3 positivity(%)  sDF (%) 
∆Ct PRM1 r -0.135 0.222 
p 0.387 0.153 
∆Ct PRM2 r -0.134 0.230 
p 0.390 0.138 
∆Ct TNP1 r -0.179 0.133 
p 0.250 0.397 
∆Ct TNP2 r -0.171 0.039 
p 0.305 0.814 
∆Ct H2BFWT r -0.038 -0.023 




r -0.091 0.100 
P 0.560 0.524 
 
By examining the correlation between the mRNA  relative amount  of the studied genes 
(TNP1, TNP2, PRM1, PRM2, and H2BFWT), and protamine deficiency (CMA3 positivity) 
as well as sperm DNA fragmentation (sDF), no correlation has been shown either in non-
smokers (Table 25) or in heavy-smokers (Table 26), a correlation could not be found. 
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Table 26: Correlation between the mRNA relative amount of the studied genes, protamine 
deficiency (CMA3 positivity) and sperm DNA fragmentation (sDF) in the case group 
(heavy-smokers, n=98) 
  
CMA3 positivity (%) Sperm DNA 
fragmentation (sDF) 
(%) 
∆Ct PRM1 r 0.036 -0.055 
p 0.722 0.587 
∆Ct PRM2 r 0.165 0.069 
p 0.104 0.499 
∆Ct TNP1 r 0.002 -0.008 
p 0.982 0.935 
∆Ct TNP2 r 0.029 -0.039 
p 0.789 0.721 
∆Ct H2BFWT r 0.076 -0.002 
p 0.469 0.983 
Protamine (P1–P2) 
mRNA ratio 
r 0.413** 0.302** 
p 0.0001 0.003 
 
Nevertheless, in the heavy smokers’ group (Table 26), the protamine mRNA ratio showed 
a high positive correlation with both protamine deficiency (CMA3 positivity) and sperm 
DNA fragmentation (sDF) (r= 0.413, p=0.0001; r=0.302, p=0.003 respectively). 
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3.2.9. Correlation between the relative expression levels of the studied genes: 
H2BFWT, TNP1, TNP2, PRM1 and PRM2 
Table 27: Correlation between the mRNA relative amount of the studied genes in the 
















∆Ct PRM1 r 1.000 0.961** 0.920** 0.731** 0.257 0.299 
p 
 
0.0001 0.0001 0.0001 0.110 0.052 
∆Ct PRM2 r 0.961** 1.000 0.887** 0.709** 0.237 0.488** 
p 0.0001 
 
0.0001 0.0001 0.141 0.001 
∆Ct TNP1 r 0.920** 0.887** 1.000 0.737** 0.236 0.294 
p 0.0001 0.0001 
 
0.0001 0.142 0.055 
∆Ct TNP2 r 0.731** 0.709** 0.737** 1.000 0.487** 0.349* 





r 0.257 0.237 0.236 0.487** 1.000 0.229 




In the non-smokers group (Table 27), the relative expression level of the H2BFWT 
correlated positively with the relative amount of TNP2 mRNA (r=0.487, p=0.003).   
Moreover, the relative expression levelof TNP1 showed a highly positive correlation 
(p=0.001) with the expression levels of TNP2, PRM1, and PRM2 (r=0.737, r=0.920, 
r=0.887). 
The TNP2 relative expression level correlated positively (p=0.0001) with the relative 
amount of PRM1 and PRM2 (r=0.731, r=0.709 respectively). 
The correlation between the PRM1 and PRM2 expression levels was a high positive 
significant correlation (r=0.961, p=0.0001). 
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The protamine mRNA ratio correlated positively with the expression levels of TNP2 
(r=0.349, p=0.032) and PRM2 (r=0.488, p=0.001). 
 
Table 28: Correlation between the mRNA relative amount of the studied genes in the case 
group (heavy-smokers, n=98) 
  










∆Ct PRM1 r 1.000 0.926** 0.859** 0.903** 0.254* 0.150 
p 
 
0.0001 0.0001 0.0001 0.014 0.139 
∆Ct PRM2 r 0.926** 1.000 0.822** 0.887** 0.398** 0.445** 
p 0.0001 
 
0.0001 0.0001 0.0001 0.0001 
∆Ct TNP1 r 0.859** 0.822** 1.000 0.814** 0.357** 0.186 
p 0.0001 0.0001 
 
0.0001 0.0001 0.066 
∆Ct TNP2 r 0.903** 0.887** 0.814** 1.000 0.354** 0.307** 





r 0.254* 0.398** 0.357** 0.354** 1.000 0.342** 




In the heavy-smokers group (Table 28), the H2BFWT expression level showed a 
significant positive correlation with the transition proteins 1 (TNP1) and 2 (TNP2) relative 
expression levels (r=0.357, p= 0.0001; r=0,354, p=0.001 respectively).  
Moreover, a positive correlation with protamines 1 (PRM1) and 2 (PRM2) mRNA relative 
amount was found (r=0.254, p=0.014; r=0.398, p=0.0001 respectively).  
The relative amount of TNP1 gene mRNA demonstrates a highly significant positive 
correlation with the following mRNA relative amounts of TNP2, PRM1 and PRM2 genes 
(r=0.814, r=0.859, r=0.822; p<0.001 respectively).  
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Similarly, the TNP2 gene mRNA relative amount showed a highly positive correlation 
(p=0.0001) to PRM1 and PRM2 expression levels (r=0.903, r=0.887 respectively).  
PRM1 and PRM2 expression levels also correlated as positively significant with each 
other's (r=0.926, p=0.0001).  
In contrast to the group of non-smokers, the protamine mRNA ratio correlated significantly 
positive to TNP2 mRNA relative amount (r=0.307, p=0.004), PRM2 mRNA relative 
amount (r=0.445, p=0.0001), and to H2BFWT mRNA relative amount (r=0.342, p=0.001) 
(Table 28). 
3.3. Investigations of single nucleotide polymorphisms (SNP) and mutations in 
H2BFWT, PRM1, and PRM2 genes 
3.3.1. Variant calling 
For each sample, primary and secondary sequences were extracted from the chromatogram 
(.ab1) files using the tool Tracy (https://github.com/gear-genomics/tracy) to obtain the 
allelic sequences for each gene. The aligner bwa (Li & Durbin, 2009) was used to map the 
resulting FASTA-reads to the hg19 reference genome. Since for each individual forward 
and reverse Sanger reads were provided, a BAM file containing four reads was produced 
for each individual in this way. Next, a set of potential SNP positions was generated. We 
used samtools mpileup (Li et al., 2009) to report all positions in the alignment files where 
at least one read carried an allele different from the reference sequence. All resulting SNP 
candidates were then genotyped in all individuals using WhatsHap (Ebler et al., 2018, 

























3.3.2. Quality Control 
From the set of all SNPs resulting from the previous steps, all positions with an allele 
frequency above 5 % across all studied individuals were selected. A set of nine SNP 
positions resulted. Three of them were located on chromosome X. Since all sequenced 
individuals were males, one would expect all of these positions to be genotyped as either 
0/0 or 1/1 since each individual carry only one X chromosome. Indeed, our genotyping 
algorithm genotyped all SNPs located on the X chromosome as 0/0 or 1/1 in all individuals. 
The remaining six SNPs were located on chromosome 16. They were tested for Hardy-
Weinberg Equilibrium using Fisher's Exact Test. Four of these six SNPs showed no 
significant deviation from HWE. We concluded that the two other SNPs, for which the test 
reported a significant deviation from HWE, might not be real variants and excluded them 
from further analysis. Hence, our final set of SNP calls contained 7 SNPs.  
Figure 19: Variant Calling. Allelic sequences were extracted from the chromatogram files and 
aligned to a reference genome. Next, variants were called and genotyped in all samples. 
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Corresponding positions (wrt. to reference sequence hg19) and alleles of these SNPs are 
shown below (Table 29). 
Table 29: Detected SNPs and their allele frequencies 









Chromosome 16  11374866 rs737008 G T 0.47 
Chromosome 16  11369534 rs424908 G A 0.99 
Chromosome 16  11369855 rs2070923 G T 0.50 
Chromosome 16  11369930 rs1646022 C G 0.30 
Chromosome X   103267865 rs553509 C T 0.72 
Chromosome X   103268241 rs7885967 G A 0.60 
Chromosome X   103268333 rs578953 G A 0.09 
 
Furthermore, we observed that our SNP calls had been reported previously by the 1000 
Genomes project (1000 Genomes Project Consortium, 2012). As an additional quality 
control, we compared the allele frequencies that we obtained for these SNPs to the ones 
reported by 1000 Genomes and observed that they matched very well. The results are 
shown in Figure 2. The blue dots correspond to the allele frequencies that we have observed 
across our samples, and the boxplots show the distribution of allele frequencies for these 





3.3.3. Distribution of SNPs in H2BFWT, PRM1 and PRM2 genes among the groups of 
heavy-smokers and non-smokers 
For each group heavy smokers and non-smokers, we computed a contingency table for each 
SNP by counting the number of reference and alternative alleles among the individuals 
belonging to the different groups. The goal was to test the association between SNP alleles 
and each of the classes. We then performed Fisher's Exact Test to find significant 
differences in allele distributions among the two groups and corrected for multiple testing 
by performing a Benjamini Hochberg correction (alpha=0.05). None of the SNPs was 
reported as being significant. All tested SNPs and corresponding allele frequencies are 
shown in Tables 30-32.  
 
 
Figure 20: Comparison to 1000 Genomes allele frequencies. We compared the allele frequencies for our detected 
SNPs (blue) to the ones previously reported by the 1000 Genomes project 
 (1000 Genomes Project Consortium, 2012) for these variants across several populations 
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3.3.3.1. Single nucleotides polymorphisms (SNP) in the H2BFWT gene 
The H2BFWT gene is located in the X chromosomes (q22.2 band). Our patients were male 
so the detected SNPs: rs7885967, rs553509 and rs578953 were homozygous SNPs. The 
same observation as for the previous genes, there were no significant differences in allele 
distribution among the heavy-smokers and non-smokers. SNP rs7885967 is located in the 5 
prime untranslated regions. The variant rs553509 was located in a coding region (Exon 1) 
and it was qualified as a missense mutation that caused an amino acid change of arginine to 
histidine. For those 2 SNPs, the alternative allele frequency was higher than the reference 
allele one (Table 29), so the number of heavy smokers and non-smokers with the 
homozygous minor-type was higher than with major homozygous one (Table 30). The 
opposite was observed for the SNP rs 578953, which is an upstream gene variant. For this 
variant, the reference allele frequency was higher than the alternative allele frequency 
(0.09). So, 8 heavy smokers and 5 non-smokers were minor homozygous (A/A), and 103 














Table 30: Recapitulation of results obtained by direct sequencing of PCR products 





ID Heavy-smokers Non-smokers p-value 
























































































NA: not applicable, NS: no significant differentiation was distinguished by comparing the genotype 















3.3.3.2. Single nucleotides polymorphisms (SNP) in the PRM1 gene 
Table 31: Recapitulation of results obtained by direct sequencing of PCR products 





ID Heavy-smokers Non-smokers p-value 



























NS: no significant differentiation was distinguished by comparing the genotype and allele frequencies 
between the heavy-smoker and non-smoker groups. 
One SNP has been identified in the PRM1 gene in the study population: rs737008. This 
SNP is a synonym variant that is located in the coding region of PRM1 (Exon 2) at position 
g.11374866G>T. There was no significant dissimilarity in allele distribution betweenthe 
heavy-smokers and non-smokers (Table 31). Thirty-two heavy smokers and fifteen non-
smokers are homozygous major G/G types, 46 heavy-smokers and 11 non-smokers were 
heterozygous (G/T), and 30 heavy smokers and 7 non-smokers were the homozygous minor 
type (T/T) (Table 31). 
3.3.3.3. Single nucleotides polymorphisms (SNP) in the PRM2 gene 
Table 32 shows that 3 SNPs have been found in the PRM2 gene. Two changes were 
detected in the intronic region (rs2070923 and rs1646022) and one was located in the 3 
prime untranslated regions (rs424908). There were no significant differences in allele 
distribution among the heavy-smokers and non-smokers. For the first variant, in the 
intronic region, at position g.11369930 G>C, 15 heavy-smokers and 4 non-smokers were 
minor homozygous (G/G), 38 Heavy smokers and 9 non-smokers were heterozygous (C/G), 
and 58 heavy smokers and 19 non-smokers were major homozygous (C/C). The second 
intronic variant was also distributed in three groups: 31 patients of the heavy-smokers 
group and 12 of non-smokers ones were minor homozygous (T/T), 47 heavy smokers and 
11 non-smokers were heterozygous (G/T), and 33 heavy smokers and 9 non-smokers were 
major homozygous (G/G). The SNP rs424908 was minor homozygous SNPs (A/A) with an 
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allele frequency of 0.99 across all samples (Table 29) and only one patient for each of the 
studied groups was heterozygous (G/A).  
Table 32: Recapitulation of results obtained by direct sequencing of PCR products 
including the PRM2 gene (Genomic and allelic frequencies are denoted) 
UTR: untranslatedregion 
NA: not applicable, NS: no significant differentiation was distinguished by comparing the genotype 
and allele frequencies between the heavy-smoker and non-smoker groups. 
3.3.4. Association between SNPs and standard sperm parameters, protamine 
deficiency (CMA3 positivity), sperm DNA fragmentation, and clinical outcomes after 
ICSI therapy 
In order to investigate the association between SNPs and standard sperm parameters, 
protamine deficiency (CMA3 positivity), and sperm DNA fragmentation (sDF), a Wilcoxon 
rank-sum test was performed for each combination of SNP and phenotype. The goal was to 






ID Heavy-smokers Non-smokers p-value 



















































































For each SNP position and each sperm parameter, we first compared the distribution of 
values for individuals with genotype 0/1 and 1/1 to the distribution of values for individuals 
with genotype 0/0. Next, we compared distributions for genotypes 0/0 and 0/1 to the 
distributions for individuals with genotype 1/1. We again corrected for multiple testing by 
applying a Benjamini Hochberg correction (alpha=0.05). None of the SNPs showed a 
significant association with any of the phenotypes and the resulting p-values for each 




















4.  DISCUSSION 
According to WHO, a significant proportion of the population is affected by infertility and 
subfertility (WHO, 2017). For this reason, more research is needed, especially in 
developing countries, to improve infertility and subfertility diagnosis, regulation and 
therapy. 
Infertility is a complicated condition affected by particular or several physiological and 
physical factors. The highest proportion of human infertility can be correlated with a 
person’s age, lifestyle, environmental factors and physical state (Das et al., 2017). To 
recognize the connection between the reasons for infertility, which are responsible for the 
regulation of the expression of genes involved in fertility, genetic factors, and aberrant 
epigenetic mechanism may lead to an understanding of as yet unidentified reasons for 
reproductive infertility (Bjornsson et al., 2004; Liu & Tollefsbol, 2008; Bunkaret al., 
2016). 
Several lifestyle behaviours, such as nutrition, sport, drinking alcohol and tobacco smoking 
are reported to have an influence on both male and female reproductive health, and, in a 
number of cases, they may have an effect on epigenetic mechanism alterations, which may 
be associated with major common human maladies (Alegría-Torres et al., 2011; Sharma et 
al., 2013). 
Around 46 % of males of reproductive age between 20- and 39-years-old are cigarette 
smokers (Ng et al., 2014). Almost 75% of men that are daily smokers are living in 
countries that have a medium or high human development index (Drope et al., 2018). 
For this reason, we focused, in this current study, on the influence of tobacco smoke on the 
male reproductive function: sperm parameters, sperm DNA quality and integrity and the 
possible genetic and epigenetic alterations by focusing on H2BFWT, TNP1, TNP2, PRM1 
and PRM2 genes. Moreover, we investigated the consequences of this on ICSI outcomes. 
4.1. Smoking and semen parameters 
Burning tobacco is highly dangerous for almost every organ system in the human body. It 
causes the release of more than 7000 toxic chemicals, mutagenic elements, and at least 70 
familiar carcinogens (Dropeet al., 2018). Nicotine is one of these chemicals that makes 
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someone addicted to tobacco smoke. In male smokers, the serum and seminal levels of 
cotinine and trans-3´-hydroxycotinine (nicotine metabolites) (Zhu et al., 2013), are 
approximately similar, whereas the serum nicotine levels were lower than the seminal 
levels (Pacifi et al., 1993). Pacifi and his colleagues demonstrated the the levels of cotinine 
in seminal plasma had a positive correlation with the sperm motility type progressive (PR) 
but negatively with the total sperm motility (Pacifi et al., 1993). Chen and Kuo (2007) 
demonstrated that cotinine levels in semen had negative effects on sperm count, motility 
and normal morphology. 
Another study showed that cotinine in seminal plasma reduces sperm parameters. It can 
therefore be used as a biomarker for smoking by patients that have fertility problems 
(Hammadeh et al., 2010).  
However, heavy metals, like lead and cadmium, are the crucial compounds in tobacco 
thataffect the sperm parameters. It was reported that blood and seminal cadmium levels 
depend on the number of cigarettes smoked and showed a positive correlation with the 
number of daily smoked cigarettes per year (Oldereid et al., 1994).  Moreovers, in 
abnormal spermatozoa, the cadmium and lead levels in seminal plasma had a negative 
correlation with sperm parameters (concentration, motility and abnormal morphology) 
(Pant et al., 2015). 
In the current study, we found in our heavy-smokers group (n=113) a significant decrease 
(p<0.01) in standard semen parameters, namely, sperm concentration, progressive motility 
(PR), and sperm normal morphology, in comparison to our non-smokers group (62.17 ± 
51.68 mill/ml vs. 88.09 ± 63.42 mill/ml, 14.86 ± 10.95% vs. 27.31 ± 21.78%, and 4.01 ± 
2.88% vs. 10.87 ± 12.11% respectively). However, semen volume and total motility 
(PR+NP) were not significantly reduced in heavy-smokers in comparison to non-smokers 
(Table 5). 
The present results are in accordance with various other studies that reported the toxic 
elements in tobacco smoking to have negative effects on semen quality (El-Melegy & Ali, 
2011; Joo et al., 2012; Anifandis et al., 2014; Hamad et al., 2014). The Practice Committee 
of the American Society for Reproductive Medicine also disclosed in 2012 that the 
relationship between tobacco consumption and reduced sperm parameters is a dose-
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response relationship (Practice Committee of the American Society for Reproductive 
Medicine, 2012). In a meta-analysis, Sharma et al. (2016) concluded that smoking had a 
generally negative influence on standard semen parameters and this was generally more 
obvious in infertile male patients than in the common population because the spermatozoa 
are probably more sensitive to the inhaled toxic chemicals (Sharma et al., 2016). 
Nevertheless, other studies reported that smoking had no meaningful effect on conventional 
sperm parameters (Saleh et al., 2002b; Trummer et al., 2002; Martini et al., 2004; Sepaniak 
et al., 2006). Therefore, further studies at the molecular level are needed to find out how 
tobacco smoking affects sperm function and to shed more light on the clinical condition. 
4.2. Smoking and sperm DNA damage 
Spermatozoa chromatin has a specific composition in comparison to somatic cell chromatin 
and the gradual transition of a histone to a protamine during spermatogenesis is a critical 
process for normal sperm function. In fact, chromatin tight packaging in spermatozoa is 
essential to protect the paternal genome against endogenous and exogenous agents, such as 
genotoxic or mutagenic agents, free radicals and nucleases, and to deliver it safely to the 
oocyte (Rathke et al., 2014). 
Any defect occurring at any of the steps of spermatogenesis and leading to chromatin 
remodelling may cause damage to DNA integrity, which may in turn influence the sperm 
morphology and motility, and consequently lead to male infertility. The sperm will then be 
rendered incapable of intruding into the oocyte or fail to fertilize it (Spano et al., 2005). 
However, it has also been demonstrated that the vitality, motility and morphology of 
spermatozoa with DNA damage can be normal and enable the sperm to fertilize the oocyte 
(Yamauchi et al., 2012). This fertilization depends on both the oocyte quality and the DNA 
damage degree to the spermatozoa (Ménézo et al., 2010). In the event of the oocyte not 
being able to effectively repair sperm DNA damage, the probability of fertilization is low 
or nil and the risk of embryonal abnormality development will be higher (Bungum & 
Oleszczuk, 2018). 
Thus, there are always discussions about the use of the various techniques for measuring 
sperm DNA fragmentation and/or compaction as a supplementary test to predict the results 
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of such assisted reproductive techniques (Bach & Schlegel, 2016; Amiri-Yekta et al., 
2017). 
A number of studies have demonstrated that spermatozoa in the ejaculates of infertile men 
showed more DNA fragmentation (accumulation of several double or single-stranded DNA 
breaks) than was the case in fertile men (Irvine et al., 2000; Lewis et al., 2013). 
The main causes of DNA alteration were reported to be the defective repair of double or 
single-stranded DNA breaks caused by topoisomerase II during chromatin remodelling 
(Leduc et al., 2008), abortive apoptosis (Sakkas et al., 2004), aberrant protamination (Aoki 
et al., 2005; Steger et al., 2007; Castillo et al., 2011), abnormal expression of transition 
proteins (Meistrich et al., 2003; Suganuma et al., 2005), interaction between toxic 
chemicals and/or heavy metals with protamines (Quintanilla-Vega et al., 2000), and 
oxidative stress (Aitken et al., 2014). 
In the last decade, more studies were focussed on the mechanisms by means of which 
environmental and lifestyle factors, especially smoking, have an influence on the sperm 
genome and epigenome (Harlev et al., 2015) and have a potential effect on the developing 
embryo (Beal et al., 2017; Donkin & Barrès, 2018). 
Tobacco smoking is in fact associated with high levels of seminal reactive oxygen species 
(ROS) causing oxidative DNA damage (Hammadeh et al., 2010; Kumar et al., 2015; La 
Maestra et al., 2015; Opuwari & Henkel, 2016). It has also been reported that tobacco 
smoke contents are correlated with DNA adduct formation leading to DNA damage (Perrin 
et al., 2011; Phillips & Venitt, 2012). 
The following two techniques were used in the current study to evaluate the sperm DNA 
integrity: terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) for 
sperm DNA fragmentation (sDF) assessment, and chromomycin A3 (CMA3) staining for 
protamine deficiency (CMA3 positivity) assessment. In the heavy-smokers group, the mean 
percentage of sDF and CMA3 positivity were significantly higher than that of the non-
smokers group (26.86 ± 19.77% vs.14.23 ± 13.07%, p = 0.0001; 33.30 ± 23.33% vs. 20.35 
± 13.43%, p = 0.001 respectively) (Table 11).  
These results are in line with a number of studies that used different techniques for the 
determination of sperm DNA fragmentation. Most of the human researches using a TUNEL 
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assay demonstrated that the levels of DNA fragmentation in smokers was higher than in 
non-smokers (Sepaniak et al., 2006; Hammadeh et al., 2010; Aydin et al., 2013). Similar 
results were found in other studies using different techniques to evaluate DNA 
fragmentation (Mitra et al., 2012; El-Melegy & Ali, 2011; Taha et al., 2014; Cui et al., 
2016). Contradictory studies, however, have concluded that smoking and DNA damage had 
no correlation (Bojar et al., 2013; Bounartzi et al., 2016). 
On the other hand, a significant positive correlation has been found between protamine 
deficiency (CMA3 positivity) and sperm DNA fragmentation (sDF) (r=0.484, p=0.0001) in 
the group of heavy-smokers (Table 17), but there was no correlation (r=0.256, p=0.098) 
between these two parameters in the non-smokers group (Table 18). Similar results have 
been demonstrated by other groups who reported that abnormal protamination leads to 
abnormal chromatin condensation and raises the sensitivity of sperm DNA to external stress 
causing an oxidative attack (Hammadeh et al., 2010; Ni et al., 2014; Hammadeh et al., 
2016; Ni et al., 2016).  
In the heavy-smokers group (Table 17), the mean percentage of the sperm concentration 
correlated negatively with the CMA3 positivity (r=-0.233, p=0.021) and the sDF (r=-0.263, 
p=0.009). A similar situation was observed in the non-smokers group (Table 18), the sperm 
DNA fragmentation sDF being correlated negatively with the mean percentage of total 
motility (r=-0.304, p=0.048), the mean of progressive motility (r=-0.304, p=0.047) and the 
mean percentage of morphologically normal spermatozoa (r=-0.361, p=0.017). These 
results support the claim that the DNA damage in sperm influences negatively the sperm 
quality, thereby confirming earlier studies (Arabi, 2004; Tarrozi et al., 2009; Smit et al., 
2010).  
However, a number of studies have not succeeded in demonstrating a relationship between 
traditional seminal parameters and sperm DNA damage (Henkel et al., 2004; Sepaniak et 
al., 2006; Hammadeh et al., 2010). 
Moreover, the use of different techniques to measure alterations in sperm DNA has been a 
controversial issue in the field of assisted reproduction field. Bungum et al. (2006) 
demonstrated that the pregnancy rate after intrauterine insemination (IUI) decreased when 
the DNA fragmentation index (DFI) was higher than 20%. In other studies, it was 
concluded that couples who did not become pregnant after IVF treatment had a DNA 
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fragmentation higher than 25% and their embryo quality correlated negatively with sDF 
(Simon et al., 2011). According to a study conducted by Oleszczuk et al. (2016), DFI 
above 40% is correlated with a danger of early miscarriage.  
In the present study, by comparing the clinical investigated parameters between the heavy-
smokers group and non-smokers group, the pregnancy rate was seen to be significantly 
elevatedin the group of non-smokers in comparison to the heavy-smokers group (0.60 ± 
0.49% vs. 0.38 ± 0.48%; p=0.013) but other parameters showed no significant differences 
(Table 12). This is similar to the results of a study done on couples that had a normal 
conception but the male partner was a smoker; this study demonstrated that smoking has 
negative effects on fecundity and the time-to-pregnancy in a dose-dependent manner 
(Hassan & Killick, 2004). 
Low fecundity in smokers has also been reported to be related to acrosin activity (Mulla et 
al., 1995). The correlation between smoking and the sperm’s ability to fertilize the oocyte 
was also studied by Sofikitis and his colleagues (2000), who demonstrated that smoking 
correlates negatively with the sperm’s potential to fertilize the oocyte (Sofikitis et al., 
2000).  
Furthermore, toxic elements resulting from tobacco combustion have been proved to 
decrease the mitochondrial activity and cause impairment in chromatin organization and, as 
a result, altering the fertilization capability (Calogero et al., 2009; Sharma et al., 2013). 
In the present study, in the heavy-smoker group, the fertilization rate, the number of 
cleaved embryos, the number of grade 1 embryos, the number of grade 2 embryos, and the 
embryos’ grade score had a correlation neither with the mean percent of protamine 
deficiency (CMA3 positivity) nor with sperm DNA fragmentation (sDF) (Table 20).  
These results are in agreement with other studies, which reported no significant correlation 
between the fertilization rate, the quality of the embryo and pregnancy rates after IVF or 
ICSI (Chohan et al., 2004; Hammadeh et al., 2006; Zini et al., 2011; Zhang et al., 2015). 
Henkel and his team (2004) showed that there was no correlation between DNA 
fragmentation (TUNEL assay) and the fertilization rate. Similar results had been found 
earlier by Benchaieb et al. (2003), who found no correlation between DNA fragmentation 
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(TUNEL assay) and embryo quality.  In both groups, however, it was shown that sperm 
DNA damage has an adverse effecton pregnancy, and more recently Amiri-Yekta et al. 
(2017) came to the same conclusion. 
In contrast, in the non-smokers group, the mean percentage of the sperm DNA 
fragmentation (sDF) correlated positively with the number of cleaved embryos (r=0.394, 
p=0.009), the number of grade 1 embryos (r=0.341, p=0.025), and the number of grade 2 
embryos (r=0.316, p=0.039) (Table 19). This coincides with the results from a study 
conducted by Payne and his colleagues in which they demonstrated that the higher the 
sperm DNA fragmentation is, the higher the pregnancies result is (Payne et al., 2005). This 
contradiction can be explained by the fact that, after fertilization, a good quality oocyte is 
capable of repairing the sperm DNA damage (Ménézo et al., 2010) but, if not, this can have 
a negative impact on the embryo development (Giwercman et al., 2010). 
The current study strongly suggests that CMA3 staining and TUNEL measuring the sperm 
DNA alterations (compaction and fragmentation respectively) caused by various factors, 
such as tobacco smoking, may be useful as supplementary test before any ART treatment to 
ensure a good prognosis especially in cases of idiopathic infertility and repetitive 
miscarriage.   
4.3. Tobacco smoking and epigenetic changes in studied genes: H2BFWT, 
TNP1, TNP2, PRM1 and PRM2 
Epigenetic modifications in the sperm epigenome are additional evidence of the possible 
influence of environmental factors on sperm chromatin reorganization. Epigenetics is 
defined as modifications in gene expression originated by processes different from 
modifications in the encoding DNA sequence (Li, 2002). Such modifications may be 
transferred during cell divisions (Boissonnas et al., 2013).  
There is growing evidence that some lifestyle factors, such as nutrition, stress, alcohol 
consumption, and tobacco smoking, induce epigenetic modulation affecting male fertility 
(Alegría-Torres et al., 2011; Sharma et al., 2013). 
Spermatogenesis is an epigenetically elevated controlled process and any interruption at 
any phase might be a reason of male infertility (Das et al., 2017). Progressive 
protamination of the sperm genome during spermiogenesis leads to the elimination of 
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histones carrying epigenetic signals. Thus, protamination plays a part in the epigenetic 
regulation of the spermatozoa and any environmental factor affecting protamination may be 
considered as an epigenetic signal, such as DNA methylation and histone modification, 
influencing the transcription regulation after fertilization (Donkin & Barrès, 2018). 
In addition, human spermatozoa carry a different kind of mRNA molecules (>5000 types) 
containing at least 100 miRNAs (Güneş & Kulaç, 2013; Castillo et al., 2015). Until now, 
the exact function of these mRNA molecules is still not clear because the protein synthesis 
is disabled in spermatozoa (Savadi‐Shiraz et al., 2015). A number of studies have 
demonstrated that the sperm transcript accompanies the paternal genome throughout 
fertilization and consequently affects the early embryo development (Jodar et al., 2013; 
Sendler et al., 2013). 
Testis-specific histones or histone variants, such as H2BFWT, transition proteins TP1 and 
TP2 and protamines P1 and P2 present the main nuclear proteins that have a crucial role in 
the morphology and function of mature spermatozoa. We have, therefore, focused on the 
relative quantification of H2BFWT, TNP1, TNP2, PRM1 and PRM2 gene expression by 
quantifying the mRNA or transcript levels of each gene of interest, in order to determine if 
these transcripts may be used as biomarkers to understand more fully and to evaluate the 
sperm function.  At the same time, we investigated the influence of tobacco smoking on the 
transcript level of each of these investigated nuclear proteins. 
The first step in spermatogenesis takes place in round spermatids and includes the 
substitution of nearly 85% of somatic histones with testis-specific histone variants that are 
themselves supplanted by TP1 and TP2. Secondly, the protamines P1 and P2 take the place 
of the transition proteins in elongating spermatids leading to a highly compacted and 
transcriptionally silent sperm chromatin (Carrell et al., 2007). 
H2BFWT is one of two H2B variants that are present in the male gamete. The only 
information known about H2BFWT is that this histone variant’s main function is the 
facilitation of the transition histone-protamine and the epigenetic control of gene 
transcription and its association with telomeres, which suggests a putative role in early 
chromatin remodelling at fertilization (Churikovet al., 2004a). 
Moreover, the transition nuclear proteins play an important role as intermediaries in 
histone-protamine replacement in sperm chromatin. TNP1 is localized on chromosomes 2, 
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and code for transition protein TP1, which is important in DNA repair mechanisms, the 
reduction of the interaction DNA-nucleosome core (Singh & Rao, 1988), in addition to 
TP2, are all needed for the complete editing of protamine P2 (Meistrich et al., 2003). In 
contrast to TNP1, TNP2 expression has been demonstrated to be different between 
mammals (Steger et al., 1998). TP2 is a DNA-compacting protein necessary to initiate the 
binding of protamine to the DNA (Kundu & Rao, 1996). 
The protamine genes PRM1 and PRM2 are located beside the transition protein 2 gene 
TNP2 on chromosome 16: 16p13.3 forming a multigenic cluster (Oliva, 2006). This cluster 
is bordered by the matrix attachment regions (MARs) containing repetitive alanine 
elements that present sites of methylation. These MARs are important for the appropriate 
regulation of protamine genes expression, independent of the methylation state (Schmid et 
al., 2001). 
Gene silencing is mediated by methylation and its activation is mediated by 
hypomethylation, which permits the binding between the nuclear matrix and chromatin, 
thereby retaining a targeted opening of the chromatin domains known as potentiation 
(Schmid et al., 2001). It has been reported that in late pachytene spermatocytes, the 
protamine cluster is potentiated and then transcribed later in round spermatids (Martins & 
Krawetz, 2007b). PRM1-PRM2-TNP2 gene loci include a TATA-box, which is important 
for the initiation of transcription by facilitating the binding of transcription factors to the 
promoter. The transcription is also regulated by binding between cAMP-response elements 
(CRE) and a number of CRE proteins (Tamai et al., 1997). Finally, the transcriptional 
suppression or activation is directed by binding between the upstream regulatory sequences 
in the promoter region and different trans-regulatory transcription factors (Queralt & Oliva, 
1995). 
Once transcribed, protamine transcripts are saved as ribonucleoproteins (RNPs), which are 
translationally repressed and translated later in elongated spermatids (Oliva et al., 1988). 
4.3.1. The relative expression level of the studied genes 
In the non-smokers group, we found that the relative expression level of the H2BFWT 
correlated positively with the relative amount of TNP2 mRNA (r=0.487, p=0.003). The 
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relative expression level of TNP1 showed a highly positive correlation (p=0.001) with the 
expression levels of TNP2, PRM1, and PRM2 (r=0.737, r=0.920, r=0.887) (Table 27). 
The TNP2 relative expression level correlated positively (p=0.0001) with the relative 
amount of PRM1 and PRM2 (r=0.731, r=0.709 respectively). Furthermore, the PRM1 and 
PRM2 expression levels showed a highly positive significant correlation (r=0.961, 
p=0.0001) (Table 27). 
This was the first study to examine the relative amount of the H2BFWT gene and its 
correlation to the transition proteins and protamines. 
These findings are in agreement with other studies which reported that H2BFWT is 
synthesized in the human testes and combined to sperm nuclei during spermatogenesis 
(Chrikov et al., 2004a; Wu et al., 2015) and associated with chromatin compaction during 
spermiogenesis (Gineitis et al., 2000). The correlation between the H2BFWT and TNP2 
gene expression levels indicate an association between these two proteins and the 
probability that this testis-specific histone may be replaced by TP2 during chromatin 
condensation, but further studies are needed to fully understand this synchronization. 
The correlation between the expression levels of TNP1, TNP2, PRM1 and PRM2 are in 
accordance with the results of other studies indicating that during chromatin remodelling 
the transition proteins TP1 and TP2 are supplanted by the protamines P1 and P2 (Oliva & 
Dixon, 1991; Balhorn, 2007; Rathke et al., 2014; Bao & Bedford., 2016). 
In fact, transition protein and protamine mRNA are similarly expressed in high quantities in 
round spermatids (Oliva, 2006; Balhorn, 2007) and their protein shows a significant 
presence in the nuclei of elongating spermatid (Wu et al., 2000; Meistrich et al., 2003). 
Moreover, a deletion of TNP1 or TNP2 leads to an alteration in PRM2 and consequently a 
defect in chromatin condensation (Yu et al., 200; Zhao et al., 2001). 
The relative proportion of protamine quantities P1 and P2 has been proposed in many 
studies as a biomarker of the maturity and integrity of the sperm chromatin (Oliva, 2006; 
Hammadeh et al., 2010; Amor et al., 2017). 
The protamine mRNA ratio, in the non-smokers group, correlated positively with the 
expression levels of TNP2 (r=0.349, p=0.032) and PRM2 (r=0.488, p=0.001) (Table 27). 
This result is in agreement with other studies, demonstrating that the protamine ratio 
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(P1/P2) deregulation is correlated to P2, more than P1 deregulation (Aoki et al., 2005; 
Hammadeh et al., 2010; Barrachina et al., 2018). 
The correlation between the protamine the mRNA ratio and TNP2 can be clarified by the 
reality that the TNP2 gene and PRM2 gene are simultaneously regulated and expressed 
because they are in the same locus (Schlüter et al., 1992). It is also believed that the PRM2 
gene is a homologue to the TNP2 gene and has similar functions (Kramer et al., 1998). 
By examining the relative amounts of the studied genes mRNA in the heavy-smokers group 
(Table 28), we found that the H2BFWT expression level showed a significant positive 
correlation to the transition proteins 1 (TNP1) and 2 (TNP2) relative expression levels 
(r=0.357, p= 0.0001; r=0,354, p=0.001 respectively) and to protamines 1 (PRM1) and 2 
(PRM2) mRNA relative amount (r=0.254, p=0.014; r=0.398, p=0.0001 respectively).  
The relative amount of TNP1 gene mRNA demonstrated a highly significant positive 
correlation with the following mRNA relative amounts of TNP2, PRM1 and PRM2 genes 
(r=0.814, r=0.859, r=0.822; p<0.001 respectively) (Table 28). 
Similarly, the TNP2 gene mRNA relative amount showed a highly positive correlation to 
PRM1 and PRM2 expression levels (r=0.903, r=0.887 respectively; p=0.0001) and the 
same type of association was observed between the PRM1 and PRM2 expression levels 
(r=0.926, p=0.0001) (Table 28). 
Notwithstanding, the protamine mRNA ratio correlated positively to TNP2 mRNA relative 
amount (r=0.307, p=0.004), PRM2 mRNA relative amount (r=0.445, p=0.0001), and 
H2BFWT mRNA relative amount (r=0.342, p=0.001) (Table 28). 
The relative amounts of each studied gene mRNA (mean delta ct) were differentially 
expressed between the heavy-smokers and non-smokers groups and this difference was 
highly significant (p<0.01) (Table 13).Moreover, H2BFWT, TNP1, TNP2, PRM1 and 
PRM2 genes were down-regulated in the spermatozoa of heavy-smokers compared to that 
of non-smokers (Fold change <0.5) (Table 14).  
Moreover, the protamine mRNA ratio, in the current study, was significantly higher in the 
heavy-smokers group in comparison to the non-smokers group (0.11 ± 0.84 vs. 0.60 ± 1.08, 
p=0.001) (Table 13). Unlike the group of non-smokers (Table 25), in the group of heavy-
smokers, the protamine mRNA ratio significantly correlated with the protamine deficiency 
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(CMA3 positivity) (r=0.413, p=0.0001) and sperm DNA fragmentation (sDF) (r=0.302, 
p=0.003) (Table 26).   
Our results confirm the previous studies in our laboratory carried on by Hammadeh et al. 
(2010), who disclosed that the protamine 2 (P2) was under-expressed in the group of 
smokers in comparison to the non-smokers group and that the protamine ratio (P1/P2) was 
significantly elevated in the smokers’ group. 
Furthermore, they found that the levels of 8-OHdG, ROS, MDA and cotinine correlated 
significantly and were significantly higher in the group of smokers in comparison to the 
non-smokers. Protamine P2 concentration and 8-OHdG correlated negatively and 
protamine ratio (P1/P2) correlated positively with 8-OHdG, confirming the association 
between DNA oxidative damage caused by smoking and protamination abnormalities in 
sperm chromatin (Hammadehet al., 2010). Hamad et al. (2017) demonstrated also that 
smoking has negative effects on protamine PRM1 and that the PRM2 gene expression and 
protamine transcript ratio was also significantly higher in the smoker group (Hamad et al., 
2017).  
Other studies have demonstrated that PRM1 and PRM2 transcripts levels were low in 
asthenozoospermic and oligozoospermic men (Aoki et al., 2006; Kempisty et al., 2007) in 
teratozoospermic men (Savadi-Shiraz et al., 2015) and generally in infertile men (Jodar et 
al., 2013) in comparison to normozoospermic men. Moreover, others are of the opinion that 
the protamine transcript ratio can be adapted to discriminate between fertile and infertile 
men (Depa-Martynow et al., 2012; Rogenhofer et al., 2013) and the ratio (P1/P2) was high 
in patients having fertility problems (Ni et al., 2016) and correlated with high sperm DNA 
fragmentation (Castillo et al., 2011; Simon et al., 2011; Hammadehet al., 2010; Ribas-
Maynou et al., 2015; Amor et al., 2018). 
This study is unique as it is the first, to our knowledge, to investigate the influence of 
smoking on the histone variant H2BFWT and the expression of the transition proteins 
TNP1 and TNP2. A number of studies have examined the correlation between these genes’ 
expression level and male infertility. They have found that TNP1, TNP2, and HILS1 
mRNA levels are lower in the spermatozoa of asthenozoospermic patients compared to 
normozoospermic ones (Jedrzejczak et al., 2007), but another study, by Savadi-Shiraz et al. 
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(2015) found that the TNP2 transcript level is higher in teratozoospermic patients compared 
to normal ones. Moreover, the downregulation of H2BFWT was found to be related to 
altered spermatogenesis (Van Roijen et al., 1998; Churikov et al., 1998). 
Hamad et al. (2014) concluded that male smoking is related to a high histone-(H2B)-to-
protamine ratio, causing an alteration in sperm DNA. Yu et al. (2014) confirmed this 
previous study and added that the histone-protamine transition and the transcription of 
protamine genes can be affected by tobacco smoking. An earlier study reported that TSH2B 
was expressed differently in infertile patients (Van Roijen et al., 1998). De Yebraet al. 
(1993) and Zhang et al. (2006) showed a high ratio of histone levels to total nuclear protein 
in infertile patients.  
Selit et al. (2012) reported that sperm DNA and RNA are negatively affected by smoking. 
Moreover, tobacco smoking is responsible for the down-regulation of mir-469, mir-466, 
mir450-b, mir-421, and mir-34b (Dashwood & Ho, 2007; Izzotti et al., 2011; Wei et al., 
2015). 
Cui and his colleagues (2016) pointed out that the smoking habit is associated with an 
alteration of DNA integrity and inhibits DNA repair. They found that smoking was 
associated with sperm DNA fragmentation and reduced amounts of Check point kinase 1 
(Chk1) transcripts (p<0.05), which are important for the repair of sperm DNA damage. 
Nevertheless, tobacco smoke is generally considered to be one of the stronger 
environmental factors affecting DNA methylation (Lee & Pausova, 2013). It has been 
reported that nicotine adheres to nicotine acetylcholine receptors and raises the intracellular 
calcium, causing the downstream activation of the cAMP response element-binding protein, 
the main transcription factor of a great number of genes, (Shen & Yakel, 2009) including 
the genes investigated in this study (H2BFWT, TNP1, TNP2, PRM1, and PRM2).  
Satta et al. (2008) reported that nicotine downregulates the expression of a number of DNA 
methyltransferase (DNMT1) and other proteins of mouse neurons.  
In addition, smoking is a major source of ROS, which leads to oxidative stress and the 
cysteine and thiol groups (2SH) of protamine are an easy target for oxidative stress 
constituents. Cotinine, on the other hand, has a negative effect on intra- and intermolecular 
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disulfide bond formation, leading to less chromatin compaction in sperm and a high 
percentage of DNA fragmentation (Kemp et al., 2008) 
Benzopyrene and vinyl chloride, other components of cigarette smoking, increase the 
linking of DNA adducts, which then participate in improper DNA replication and 
inaccurate protein synthesis (Ménézo et al., 2010).  
Other studies have demonstrated that an aberrant protamine ratio (P1/P2) is correlated to 
male infertility and it is caused by a decrease or an absence of protamine 2 (P2) expressions 
(Aoki et al., 2005, Hammadeh et al., 2010, Hamad et al., 2014; Moghbelinejad et al., 
2015). In the present study, we have found that an aberrant protamine ratio correlated to a 
decrease in protamine 2, transition protein 2 and the testis-specific histone H2BFWT 
(Table 28). However, larger prospective studies are needed to confirm these correlations 
and to clarify the mechanism at the molecular level.  
4.3.2. The relationship between the expression levels of the studied genes, sperm 
parameters, and ICSI results 
In the non-smokers group, the semen parameters showed no correlation with the transcript 
level (∆Ct) of the PRM1, PRM2, TNP1, TNP2 and H2BFWT (Table 21). However, the 
protamine (P1–P2) mRNA ratio correlated significantly negatively with the semen volume 
(r=-0.463, p=0.002) (Table 21). 
In the heavy-smokers group, the relative protamine 1 (PRM1)  and transition protein 1 
(TNP1) level correlated positively with the sperm concentration (r=0.335, r=0.391 
respectively; p<0.01), total motility (r=0.203, r=0.238; p<0.05), progressive motility 
(r=0.337, r=0.361; p<0.01), and morphologically normal spermatozoa (r=0.214, p=0.035; 
r= 0.294, p=0.003 respectively). However, the PRM2 expression level correlated 
positivelywith the sperm concentration (r=0.329, p=0.001) and the progressive motility 
(PR) (r=0.338, p=0.001) (Table 22). 
The relative expression level of TNP2 showed a highly positive correlation with sperm 
count (r=0.369, p=0.001), progressive motility (r=0.359, p=0.001) and the morphologically 
normal spermatozoa (r=0.303, p=0.004) (Table 22). 
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A significant positive correlation was also found between the relative amount of H2BFWT 
mRNA and progressive motility (r=0.230, p=0.027). Furthermore, the protamine mRNA 
ratio correlated positively significant with total motility (r=0.228, p=0.024) (Table 22). 
These findings confirm the fact that the testis-specific histone-like H2BFWT, transition 
proteins, and protamines are essential for chromatin remodelling and compaction during 
spermatid differentiation to spermatozoa, which means that they actively participate in the 
spermatozoa morphology and motility. 
The results of the present study are in accordance with the findingsof other studies that 
demonstrated a significant correlation between altered sperm parameters and abnormal 
protamine ratio (Mengual et al., 2003; Aoki et al., 2006; De Mateo et al., 2009; Simon et 
al., 2014; Hamad et al., 2014).  
Moreover, these results are in agreement with others that found that sperm motility and 
protamine transcript correlated significantly and protamine mRNA ratio correlated 
positively with sperm concentration and motility (Depa-Martynow et al., 2012; Rogenhofer 
et al., 2013).  
On the other hand, the outcomes of the present study are in contradiction to the results of 
Hamad et al. (2017), who found no significant association between protamine mRNA ratio 
and sperm motility and to the findings of others who demonstrated a negative correlation 
between progressive motility and protamine transcript level and a significant negative 
correlation between the protamine mRNA ratio and non-progressive motility (Rogenhoferet 
al., 2017). 
Nevertheless, it has been found that knock-out mice for TNP1 and TNP2 genes had a 
reduction in the following seminal parameters: progressive motility and normal 
morphology (Adham et al. 2001; Shirley et al. 2004; Miyagawa et al., 2005; Savadi-Shiraz 
et al., 2015) and that the TNP2 gene mRNA level and its protein are important for normal 
sperm development (Liu et al., 2013) and the prevention of defects in sperm morphology 
(Tseden et al., 2007). 
Taken together, there were no significant correlations between the gene expression levels 
mRNA and the clinical parameters after intracytoplasmic sperm injection ICSI was 
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observed. However, the relative amount of the TNP1 mRNA correlated negatively with the 
fertilization rate (r=0.401, p=0.008) in the non-smokers group (Table 23).  
It is also noteworthy that, although smoking affects the gene expression of spermatozoa no 
correlations were observed between the clinical parameters after ICSI (the fertilization rate, 
the number of cleaved embryos, the number of grade 1 embryos, the number of grade 2 
embryos, the embryo grade score) and the relative expression levels of H2BFWT, TNP1, 
TNP2, PRM1, and PRM2 genes in the heavy–smokers group (Table 24). 
In both groups too, the protamine mRNA ratio showed no correlation with the clinical 
parameters after ICSI (Tables 23 & 24). 
These results are inconsistent with other studies that did not notice a difference in PRM1 
and PRM2 mRNA levels (Depa-Martynow et al., 2007) and in the TNP2 mRNA level 
(Savadi-Shiraz et al., 2015) between a successful ICSI cycle and a failed one. 
However, contradictory findings have been reported (Aoki et al., 2006; de Mateo et al., 
2009; Simon et al., 2011; Rogenhofer et al., 2013), their data suggesting a correlation 
between an altered protamine (P1/P2) ratio and a lower fertilization rate, a lower embryo 
quality grade score, and a lower pregnancy score.  
Rogenhofer et al. (2017) found that the protamines PRM1 and PRM2 transcript levels and 
the protamine mRNA ratio were notably different between spermatozoa from male partners 
whose women had more than 2 miscarriages and spermatozoa from both subfertile male 
partners of couples undergoing ART treatment (IVF/ICSI) and healthy males. From this 
they concluded that protamines mRNA in human spermatozoa is important for both 
successful fertilization and early embryo development.  
The findings of this present study are in agreement with an earlier study (Shirley et al., 
2004) that found that both the fertilization rate and the embryonic development were 
reduced in TNP1-and TNP2-null mice.  
The current data also strongly suggest that these studied genes are expressed in a well-
organized chronological manner and any alterations from an internal or external factor, 
such as smoking, may alter these mechanisms and thus result in altered spermiogenesis and 
sperm function.  
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4.4. Tobacco smoking and genetic alterations in H2BFWT, PRM1, PRM2 
The genotoxic constituents of tobacco are responsible for some genetic damage to 
spermatozoa, namely, DNA adducts, single- or double-strand breaks, cross-links, 
aneuploidies, and chromosomal aberrations. If not correctly repaired, sperm DNA damage 
can lead to mutations or de novo mutations. It was found also that this mutation can be 
transmitted into the next generation and the types of mutations vary from 
insertions/deletions (indels) and single nucleotide variations (SNVs) to a greatrange of 
structural variation (Beal et al., 2017). 
In fact, nicotine and Benzo[a] pyrene have been demonstrated to cause deleterious sperm 
DNA alterations which can be transmitted to offspring (Holloway et al., 2004; Mohamed et 
al., 2010).  
Besides, recent studies demonstrated an association between genetic variations or 
polymorphisms in xenobiotic metabolism enzyme genes and male infertility in smokers like 
the variation 590G>A of N-acetyltransferase-2 gene (NAT2) (Yarosh et al., 2015), and 
4621le/Val in cytochrome P450, family1, subfamily A polypeptide 1 gene (CYP1A1) 
(Yaroshet al., 2013). 
In this current study, we looked for a possible connection between genetic variations in the 
H2BFWT gene, protamines genes (PRM1 and PRM2) and fertility alteration in heavy-
smoker and non-smoker males. 
For the H2BFWT (Xq22.2) a total of three homozygous single nucleotides polymorphism 
(SNPs): rs7885967, rs553509 and rs578953 were detected. The variant rs7885967 is 
located in the 5 prime untranslated regions. The variant rs553509 is a missense mutation 
(Arg/His) that was located in Exon 1 and rs578953 is an upstream gene variant. On testing 
the association between SNP alleles and each of the heavy-smokers and non-smokers 
groups, none of the SNPs were reported to be significant (Table 30). 
One SNP has been identified in the PRM1 gene: rs737008. This SNP is a synonym variant 
that is located on Exon 2 (Table 31). Moreover, two SNPs were detected in the intronic 
region (rs2070923 and rs1646022) and one was located in the 3 prime untranslated regions 
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(rs424908) for the PRM2 gene (Table 32). Therewere also for these two investigated genes 
no significant differences in allele distribution among the heavy-smokers and non-smokers. 
When the subjects of this study were arranged into patients without and with a variation or 
with nucleotide changes, no influences of the detected SNPs on the standard sperm 
parameters (Tables 33-35), protamine deficiency (Table 36), sperm DNA fragmentation 
(Table 37), and ICSI outcomes (Tables 38-43) were observed. 
However, this is the first study to report two variants rs424902 in PRM2 gene and rs57895 
in H2BFWT in a population of patients undergoing ICSI therapy. The other variants were 
previously reported in a number of studies testing their association with male infertility.  
However contradictory findings have been reported: some groups found an association 
between the two polymorphisms rs7885967 and rs553509 in the H2BFWT gene and male 
infertility (oligozoospermia and non-obstructive azoospermia) in the Korean population 
(Lee et al., 2009), in the Chinese population (Ying et al., 2012), and in the Iranian 
population (Rafatmanesh et al., 2018). In contrast, another study by Zargar et al. (2015) 
found no association. 
For the PRM1 variant rs737008, some studies did not find a correlation to male infertility 
as was the case in our study (Tanaka et al., 2003; Aoki et al., 2006; Ravel et al., 2007; 
Imken et al., 2009; Jodar et al., 2011; Venkatesh et al., 2011) but in a meta-analysis 
conducted on subgroups, they found a significant association between this gene 
polymorphism and male infertility (Jiang et al., 2015). 
Our results and those of others (Tanaka et al., 2003; Aoki et al., 2006; Imken et al., 2009; 
Jodar et al., 2011) demonstrated no association between the two variants rs1646022 and 
rs2070923 in PRM2 gene and infertility. However, in a meta-analysis, the rs1646022 in an 
Asian subgroup has been considered as a risk factor for male infertility (Jiang et al., 2015). 
It can, therefore, be concluded that the absence of an association between SNP alleles and 
each of the classes of heavy-smokers and non-smokers indicates that smoking induces 
epigenetic changes that alter the gene expression but it seems unlikely that it alters the 




The outcomes of the current study demonstrate that tobacco smoking had a generally 
negative influence on standard semen parameters. Smoking was also associated with high 
levels of protamine deficiency, DNA fragmentation and a low pregnancy rate. Protamine 
deficiency leads to abnormal chromatin condensation and raises the sensitivity of sperm 
DNA to external stressors, causing an oxidative attack, leading to DNA damage and 
consequently impairment of the sperm quality. 
Thus, CMA3 staining and TUNEL assay can be used for the evaluation of the negative 
effects of a variant of environmental risk factors, such as smoking, in a situation, for 
example, like idiopathic infertility where the standard measurement of semen parameters is 
not enough to provide a complete diagnostic. 
Furthermore, tobacco smoking affects the expression of the following five genes, 
H2BFWT, TNP1, TNP2, PRM1, and PRM2, as well as the protamine mRNA ratio. 
Transcripts of these genes are therefore good biomarkers in the sperm of ICSI patients to 
evaluate sperm quality and its fertilizing capacity. 
Moreover, no connection was found between the genetic variations found in the H2BFWT 
gene (rs7885967, rs553509 and rs578953), protamine genes PRM1 (rs737008) and PRM2 
(rs2070923 and rs1646022) and fertility alteration in heavy-smoker and non-smoker males.  
In conclusion, the present study has shown that smoking does indeed induce epigenetic 
changes which alter the gene expression but it seems unlikely that it alters the nucleotide 
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Supplementary Tables for Chapter 3.3.4. Association between SNPs and standard sperm 
parameters, protamine deficiency (CMA3 positivity), sperm DNA fragmentation, and 
clinical outcomes after ICSI therapy) 
Table 33: Association between the Single nucleotides polymorphisms (SNPs) and sperm 
concentration (106 per ml) 
SNPs Test p-value 
rs424908 {0/0} vs. {0/1. 1/1} - 
{0/0. 0/1} vs. {1/1} 0.9933746147277847 
rs2070923 {0/0} vs. {0/1. 1/1} 0.9389749144130906 
{0/0. 0/1} vs. {1/1} 0.4162086134220676 
rs1646022 {0/0} vs. {0/1. 1/1} 0.865806699149712 
{0/0. 0/1} vs. {1/1} 0.743865463175486 
rs737008 {0/0} vs. {0/1. 1/1} 0.7470590680767566 
{0/0. 0/1} vs. {1/1} 0.4208094054177579 
rs553509 {0/0} vs. {1/1} 0.013075074553835884 
rs7885967 {0/0} vs. {1/1} 0.0624252968856986 
rs578953 {0/0} vs. {1/1} 0.49508868402949857 






Table 34: Association between the Single nucleotides polymorphisms (SNPs) and 
progressive motility (PR.%) 
SNPs Test p-value 
rs424908 {0/0} vs. {0/1. 1/1} - 
{0/0. 0/1} vs. {1/1} 0.2803684675318613 
rs2070923 {0/0} vs. {0/1. 1/1} 0.8732777094259344 
{0/0. 0/1} vs. {1/1} 0.3345142031373297 
rs1646022 {0/0} vs. {0/1. 1/1} 0.3360119664696074 
{0/0. 0/1} vs. {1/1} 0.48973067293663575 
rs737008 {0/0} vs. {0/1. 1/1} 0.8685910748187006 
{0/0. 0/1} vs. {1/1} 0.9982207458581356 
rs553509 {0/0} vs. {1/1} 0.31528758179812033 
rs7885967 {0/0} vs. {1/1} 0.753394761339557 
rs578953 {0/0} vs. {1/1} 0.27954292428841765 












Table 35: Association between the Single nucleotides polymorphisms (SNPs)and 
morphologically normal spermatozoa (%) 
SNPs Test p-value 
rs424908 {0/0} vs. {0/1. 1/1} - 
{0/0. 0/1} vs. {1/1} 0.28783437373616927 
rs2070923 {0/0} vs. {0/1. 1/1} 0.5304279142863653 
{0/0. 0/1} vs. {1/1} 0.04737686873584445 
rs1646022 {0/0} vs. {0/1. 1/1} 0.14925943059995164 
{0/0. 0/1} vs. {1/1} 0.6240573525042739 
rs737008 {0/0} vs. {0/1. 1/1} 0.2468074490858797 
{0/0. 0/1} vs. {1/1} 0.16005734623194479 
rs553509 {0/0} vs. {1/1} 0.5169346030783695 
rs7885967 {0/0} vs. {1/1} 0.6269185540134425 
rs578953 {0/0} vs. {1/1} 0.5146999222652533 












Table 36: Association between the Single nucleotides polymorphisms (SNPs) and 
protamine deficiency (CMA3 positivity) (%) 
SNPs Test p-value 
rs424908 {0/0} vs. {0/1. 1/1} - 
{0/0. 0/1} vs. {1/1} 0.3755043873403856 
rs2070923 {0/0} vs. {0/1. 1/1} 0.37823394618353245 
{0/0. 0/1} vs. {1/1} 0.621939276796292 
rs1646022 {0/0} vs. {0/1. 1/1} 0.6640026536625103 
{0/0. 0/1} vs. {1/1} 0.10469665725189653 
rs737008 {0/0} vs. {0/1. 1/1} 0.5983378737757894 
{0/0. 0/1} vs. {1/1} 0.17098512863304105 
rs553509 {0/0} vs. {1/1} 0.42983991504241614 
rs7885967 {0/0} vs. {1/1} 0.9174186222372497 
rs578953 {0/0} vs. {1/1} 0.05393230321624033 












Table 37: Association between the Single nucleotides polymorphisms (SNPs) and sperm 
DNA fragmentation (sDF)(%) 
SNPs Test p-value 
rs424908 {0/0} vs. {0/1. 1/1} - 
{0/0. 0/1} vs. {1/1} 0.8803792333541915 
rs2070923 {0/0} vs. {0/1. 1/1} 0.744517217394393 
{0/0. 0/1} vs. {1/1} 0.18095775178707674 
rs1646022 {0/0} vs. {0/1. 1/1} 0.07503701808365268 
{0/0. 0/1} vs. {1/1} 0.9080644191000308 
rs737008 {0/0} vs. {0/1. 1/1} 0.34997829639914957 
{0/0. 0/1} vs. {1/1} 0.8785043586856714 
rs553509 {0/0} vs. {1/1} 0.4604095358234265 
rs7885967 {0/0} vs. {1/1} 0.1776852063461899 
rs578953 {0/0} vs. {1/1} 0.6776226698224479 










Table 38: Association between the Single nucleotides polymorphisms (SNPs) and number 
of fertilized oocytes 
SNPs Test p-value 
rs424908 {0/0} vs. {0/1. 1/1} - 
{0/0. 0/1} vs. {1/1} 0.3271506094332418 
rs2070923 {0/0} vs. {0/1. 1/1} 0.2593886335850649 
{0/0. 0/1} vs. {1/1} 0.6550926034477063 
rs1646022 {0/0} vs. {0/1. 1/1} 0.48339423927838554 
{0/0. 0/1} vs. {1/1} 0.03730154990781587 
rs737008 {0/0} vs. {0/1. 1/1} 0.13138212802869292 
{0/0. 0/1} vs. {1/1} 0.7769820145473822 
rs553509 {0/0} vs. {1/1} 0.7863717431014478 
rs7885967 {0/0} vs. {1/1} 0.6409038069961046 
rs578953 {0/0} vs. {1/1} 0.3496003973275277 









Table 39: Association between the Single nucleotides polymorphisms (SNPs) and number 
of cleaved embryos 
SNPs Test p-value 
rs424908 {0/0} vs. {0/1. 1/1} - 
{0/0. 0/1} vs. {1/1} 0.26706279458557747 
rs2070923 {0/0} vs. {0/1. 1/1} 0.2631388274185684 
{0/0. 0/1} vs. {1/1} 0.49233956686094926 
rs1646022 {0/0} vs. {0/1. 1/1} 0.45379632292278616 
{0/0. 0/1} vs. {1/1} 0.038779287881035324 
rs737008 {0/0} vs. {0/1. 1/1} 0.18149180857202296 
{0/0. 0/1} vs. {1/1} 0.743795165131018 
rs553509 {0/0} vs. {1/1} 0.9173305750089161 
rs7885967 {0/0} vs. {1/1} 0.40467844353878535 
rs578953 {0/0} vs. {1/1} 0.22642945601731423 









Table 40: Association between the single nucleotides polymorphisms (SNPs) and 
fertilization rate (%) 
SNPs Test p-value 
rs424908 {0/0} vs. {0/1. 1/1} - 
{0/0. 0/1} vs. {1/1} 0.8103550592026044 
rs2070923 {0/0} vs. {0/1. 1/1} 0.03205097462877848 
{0/0. 0/1} vs. {1/1} 0.23903206039691183 
rs1646022 {0/0} vs. {0/1. 1/1} 0.6151144251975146 
{0/0. 0/1} vs. {1/1} 0.03483077162368566 
rs737008 {0/0} vs. {0/1. 1/1} 0.23470723921223913 
{0/0. 0/1} vs. {1/1} 0.025423491541043317 
rs553509 {0/0} vs. {1/1} 0.014718771454381614 
rs7885967 {0/0} vs. {1/1} 0.04174337049411485 
rs578953 {0/0} vs. {1/1} 0.7763816892409101 










Table 41: Association between the single nucleotides polymorphisms (SNPs) and number 
of grade 1 embryos (G1) 
SNPs Test p-value 
rs424908 {0/0} vs. {0/1. 1/1} - 
{0/0. 0/1} vs. {1/1} 0.8103550592026044 
rs2070923 {0/0} vs. {0/1. 1/1} 0.05339003970229222 
{0/0. 0/1} vs. {1/1} 0.48886995903603236 
rs1646022 {0/0} vs. {0/1. 1/1} 0.3085498910762364 
{0/0. 0/1} vs. {1/1} 0.003794939181221096 
rs737008 {0/0} vs. {0/1. 1/1} 0.7507765647101192 
{0/0. 0/1} vs. {1/1} 0.31470590161892176 
rs553509 {0/0} vs. {1/1} 0.9173305750089161 
rs7885967 {0/0} vs. {1/1} 0.3362025017457013 
rs578953 {0/0} vs. {1/1} 0.3496003973275277 










Table 42: Association between the single nucleotides polymorphisms (SNPs) and number 
of grade 2 embryos (G2) 
SNPs Test p-value 
rs424908 {0/0} vs. {0/1. 1/1} - 
{0/0. 0/1} vs. {1/1} 0.7932402626860902 
rs2070923 {0/0} vs. {0/1. 1/1} 0.8143293315952094 
{0/0. 0/1} vs. {1/1} 0.01588018924527925 
rs1646022 {0/0} vs. {0/1. 1/1} 0.9222363838165708 
{0/0. 0/1} vs. {1/1} 0.3019768269072909 
rs737008 {0/0} vs. {0/1. 1/1} 0.012829806626289617 
{0/0. 0/1} vs. {1/1} 0.3962068790552832 
rs553509 {0/0} vs. {1/1} 0.6185276634748336 
rs7885967 {0/0} vs. {1/1} 0.5852618660581088 
rs578953 {0/0} vs. {1/1} 0.8978186803918672 












Table 43: Association between the single nucleotides polymorphisms (SNPs) and embryo 
grade score 
SNPs Test p-value 
rs424908 {0/0} vs. {0/1. 1/1} - 
{0/0. 0/1} vs. {1/1} 0.3134077545844637 
rs2070923 {0/0} vs. {0/1. 1/1} 0.9952562583457744 
{0/0. 0/1} vs. {1/1} 0.27991438124204193 
rs1646022 {0/0} vs. {0/1. 1/1} 0.9610138754251201 
{0/0. 0/1} vs. {1/1} 0.9072766392858082 
rs737008 {0/0} vs. {0/1. 1/1} 0.12465617088794856 
{0/0. 0/1} vs. {1/1} 0.818568695774981 
rs553509 {0/0} vs. {1/1} 0.9953105824678025 
rs7885967 {0/0} vs. {1/1} 0.9110792158872906 
rs578953 {0/0} vs. {1/1} 0.8356635486803874 
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